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ABSTRACT 
"Lysos.omes", which include late endosomes, are traditionally defined as membrane-bound acidic 
organelles containing hydrolytic enzymes, and are thought to be the principle site of intracellular 
digestion. F or their role in proteolysis, lysosomes are also thought be reducing, both for the 
function of the cysteine cathepsins and for the reduction of disulfide bonds in the substrate 
proteins. However, a number of observations raise the question of whether the intralysosomal 
milieu is, in fact, invariably reducing and proteolytic, or whether lysosomal function may, in 
effect, be regulated by a variable redox potential. 
To address this question three lysosomal enzymes, cathepsins S and B and acid a-glucosidase 
were isolated to assess their in vitro response to varying concentration of the reducing agent, 
cysteine. The isolation procedures devised were more rapid and cost effective than reported 
methods and gave acceptable yields. Cathepsin S was further characterized and acid 0.-
glucosidase was used as a source for the preparation of antibodies for possible further 
immunochemical and immunocytochemical studies. The effect of cysteine on these lysosomal 
enzymes supports the hypothesis that intralysosomal redox potential may constitute part of a 
regulatory mechanism for lysosomal function. 
A second approach involved qualitatively assessing the in vivo intralysosomal redox potential 
using a novel double labelling indicator system. For detecting intralysosomal oxidation cells were 
loaded with an acetoxymethyl ester derivative which fluoresces in the oxidised form, but this dye 
is not selectively loaded into lysosomes. Lysosomes can, however, be visualised using a second 
dye which selectively accumulates in cellular compartments with low internal pH. By capturing 
the two separate fluorescent images and computer analyzing them it was ascertained that the 
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Lysosomes are membrane-bound intracellular digestive organelles that function principally in 
intracellular digestion (Bainton, 1981 ; Kornfeld and Mellman, 1989). Lysosomal hydrolases are 
capable of degrading proteins, lipids, nucleic acids and saccharides (Bainton, 1981). Materials to 
be digested are incorporated within the same membrane-bound compartments as the lysosomal 
enzymes. In this way the cell deploys its enzymes economically and fosters the co-operative 
activities of a voracious group of enzymes whose actions would likely prove fatal , or at least 
damaging, were the enzymes to be released into the cytoplasm (HoltzmaIl; 1989). The 
compartmentation also facilitates the. establishment of a low pH environment within the 
lysosome, needed for the efficient activity of some of the enzymes. Lysosomes are generally 
thought to have an acidic internal milieu (Ohkuma and Poole, 1978; Yamashiro and Maxfield, 
1987a,b; Anderson and Orci, 1988) that is generated by proton pumps (Ohkuma et aI., 1982; 
Yamashiro et aI. , 1983). Consistent with this is the observation that many lysosomal enzymes 
apparently have acidic pH optima for activity (Bond and Butler, 1987; Aronson and Kuranda, 
1989). However, there is recent evidence that some lysosomal enzymes show neutral or even 
alkaline pH optima (Butor et aI. , 1995; Dehrmann et ai., 1996). Biological materials destined for 
degradation in the lysosomes are either ingested by endocytosis and shuttled to the lysosomes via 
early and late endosomes or, in the case of large particles, are taken up by phagocytosis into 
specialized macrophages resulting in the formation ofphagolysosomes (Mellman et ai., 1986). In 
a process called autophagy, obsolete endogenous cellular structures are transferred to and 
degraded in the lysosomal compartment (Dunn, 1990). However, this simple overview of 
lysosomes does not apply in straightforward fashion to all phenomena that are observed when 
studying these organelles. 
The formation of lysosomes reqUlres input from both the biosynthetic and the endocytic 
pathways. Newly synthesized lysosomal hydrolases are sorted in the trans-Golgi network by 
binding to mannose-6-phosphate specific receptors and are selectively transported to the 
endosomal compartment where uncoupling of ligand and receptor occurs. In the endosomes the 
newly synthesized lysosomal enzymes encounter the molecules on the endocytic route destined 
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for degradation. Degradative processes are likely to commence in endosomes (Peters and von 
Figura, 1994). From this compartment the lysosomal enzymes and their substrates are thought to 
be delivered to the lysosomes where degradation is completed (von Figura and Hasilik, 1986; 
Kornfeld and Mellman, 1989). At present there is no consensus on the exact molecular 
mechanisms for the formation of lysosomes. One model is based on pre-existing late endosomes 
and lysosomes communicating via transport vesicles (Gruenberg et aI. , 1989). An alternative 
model postulates a gradual maturation of early endosomes to late endosomes and subsequently to 
lysosomes by processes of continuous fusion and fission of vesicles (Stroorvogel et aI., 1991). A 
very recent hypothesis suggests that all membrane organelles in the cell should be considered 
either as vesicles or compartments (Griffiths, 1996). Vesicles are defined as membrane-enclosed 
containers that form de novo by budding off part of a pre-existing compartment, forming discrete, 
sealed particles, which generally do not fuse with themselves. A compartment is defined as a 
complex multifunctional membrane organelle, specialized for different essential cellular functions, 
which can undergo homotypic or lateral fusion with themselves but not with different 
compartments (Griffiths, 1996). 
The membrane limiting the lysosomal compartment has multiple functions. It is responsible for 
the acidification of the interior and the sequestration of highly active lysosomal enzymes capable 
of destroying cellular structures (Mellman et aI. , 1986). Furthermore, the lysosomal membrane 
mediates the transport of degradation products from the lysosomal lumen to the cytoplasm and 
regulates the fusion and fission events between lysosomes and other organelles (Haylett and 
Thilo, 1991). 
The long-term goal of the project reported here was to investigate the possibility that lysosomes 
may be subject to redox regulation. This idea arose from two observations which are not 
consistent in terms of prevailing views of the lysosome. The first is that lysosomes contain a 
large repertoire of enzymatic activities which function optimally in an acidic, reducing 
environment, which was thought to be the conditions prevailing in this organelle. Second, is the 
existence in lysosomes of a high molecular weight form of glycogen, cross-linked via disulfide-
bridged protein moieties, and which is not rapidly turned over (Geddes and Stratton, 1977b). 
These two observations create a paradox, if the intralysosomal milieu is both reducing and 
proteolytic (the conventional view), how could a molecule that has both a protein content and 
3 
disulfide linkages be stored in lysosomes? This led to the hypothesis that the redox potential of 
the internal milieu of lysosomes may be variable, and that redox potential may constitute a 
possible regulatory mechanism for lysosomal function . 
Various investigations have pointed to a role for thiols in stimulating the rate of lysosomal 
degradation of disulfide-rich proteins. Griffiths and Lloyd (1979) observed an enhanced rate of 
1251 -insulin degradation by disrupted rat liver lysosomes when reduced glutathione was added to 
incubation mixtures. Kooistra et al. (1982) found that a variety of thiols were able to stimulate 
the rate at which purified lysosomal enzymes could degrade 1251 -labelled insulin or albumin. They 
also showed that the degradation of bovine insulin or albumin by purified cathepsin D was thiol 
enhanced. Since cathepsin D is an aspartic proteinase and is thus itself not affected by thiols, and 
since no other enzyme was present, it was concluded that the role of thiol was most probably 
non-enzymic reduction of disulfide linkages, facilitating access of the proteinase to susceptible 
linkages in the substrate. This view was reinforced by subsequent data from Mego (1984), who 
showed that thiols activate proteolysis by cathepsin D only if the substrate protein contains 
disulfide bridges. Further insight into the role of thiols was provided by Kooistra et aI. (1982) 
who showed that proteolysis proceeded optimally only if thiols were present together with 
proteinases in the incubation mixture. A pre-treatment with thiol did not suffice, nor was thiol 
able to reduce all the disulfide linkages in a protein in the absence of proteinases. Lloyd (1986) 
postulated that the two processes of proteolysis and disulfide reduction act synergistically to 
facilitate lysosomal degradation of proteins. First, thiols activate the thiol-dependent lysosomal 
enzymes l (i.e. lysosomal cysteine cathepsins), and second, thiols reduce protein disulfide linkages 
allowing proteins to unfold, thereby providing proteinases access to susceptible linkages within 
the substrate. There would therefore appear to be a synergism between disulfide reduction and 
enzyme-catalysed peptide bond hydrolysis, each component process opening out the substrate 
molecule and so permitting further attack (Lloyd, 1986). 
J In their isolated forms, the cysteine cathepsins require activation with a reducing agent such as cysteine, before 
they manifest proteolytic activity. Whether this is true of these enzymes in vivo is, to my knowledge, an open 
question. 
4 
Lloyd (1986) postulated that cysteine may be the physiological agent responsible for the 
intralysosomal reduction of protein disulfides. Cysteine is abundant in the cytoplasm and seems 
to be able to cross the lysosomal membrane of normal cells (Kooistra et aI. , 1982). However, 
Kooistra et al. (1982) did not show whether this was an active or passive process. Lloyd (1986) 
suggested that cysteine may also arise in the lysosomes by degradation of cysteine-containing 
proteins. Like any other thiol, it could fully reduce a protein cysteine residue by two sequential 
reactions, but, unlike other reductants would generate a molecule of cystine in the process 
(Fig. 1). This cystine, arising not from the protein itself but from the reductant, could be 
exported from the lysosome via a cystine transporter present in the lysosomal membrane 
(Kooistra et ai., 1984; Smith et aI. , 1987). Reduction by cysteine is plausible on thermodynamic 
grounds. Cysteine and protein-bound cystine must have very similar redox potentials, and a high 
cysteine/cystine concentration ratio in lysosomes could conceivably be maintained by the 






~ Cy-SH Cy-SH I 






I SH S 
I I 
(Cy\ (Cy\ 
Figure 1. Diagram illustrating the reduction of a protein disulfide bridge by two consecutive reactions with 
cysteine (Cy-SH). 
Note that cystine (Cy-S-S-Cy) is a product of this reaction sequence and that it arises from the 
reductant and not from the cystine residue (adapted from Lloyd, 1986). 
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Subsequently a lysosomal transport system, highly specific for cysteine, was discovered by Pisoni 
et al. (1990). They proposed that this cysteine specific transporter may deliver cysteine into the 
lysosome and aid lysosomal proteolysis by reducing protein disulfide bridges and by providing 
thiol for the lysosomal thiol-dependent proteinases (see Chapter 4). Lloyd (1992), however, 
argues from the stoichiometry of the reduction reaction that there is no need for the net import of 
cysteine into the lysosome for proteolysis, and that any import is likely to constitute merely an 
anapleurotic pathway replacing cysteine that may have been oxidised to cystine. If the role of the 
cysteine transporter is not to provide cysteine as an aid to disulfide reduction concomitant with 
proteolysis, might its role be to modulate the intralysosomal redox potential, and thereby also the 
activity of lysosomal enzymes, especially perhaps proteinases? 
The disease cystinosis (Kooistra et aI. , 1984) provides an interesting case in regards to lysosomal 
redox potential. This disease, characterised by an accumulation of cystine in lysosomes, is 
believed to be caused by the incompetence of the lysosomal cystine transporter. The question 
then arises, what effect may this have on the lysosomal redox potential and consequently on 
lysosomal function? Interestingly, the renal failure characteristic of the end stage of this disease 
(Kooistra et al., 1984) is consistent with suboptimal cysteine protease activity, since renal tubules 
are rich in these enzymes which playa role in degrading re-absorbed proteins. 
Thus, for their role in proteolysis, lysosomes are thought to be reducing both for the function of 
the cysteine cathepsins and for the reduction of disulfide bonds in substrate proteins. However, 
evidence relating to lysosomal glycogen raises the question of whether the internal milieu of 
lysosomes is invariably reducing. Glycogen has both large molecular size and great polydiversity, 
and because of the latter property, any observations on its size are of little significance without 
knowledge of the distribution of the different sized particles (Geddes et aI. , 1977a). Its 
molecular weight distribution ranges from below 1 x 106 to greater than 100 x 106 daltons 
(Geddes, 1985). From electron microscopy it has been shown that glycogen is composed of 
single spherical particles of approximately 30 nm in diameter (~-particles) and clusters of these 
spheres (a-particles) which can approach 200 nm in diameter (Watson and Drochmans, 1972). 
The ~-particles, within the a-particles, have a molecular weight of approximately 107 daltons 
(Geddes et aI., 1977 a,b), and they are known to be built upon a single protein backbone 
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(Krisman and Barengo, 1975; Calder and Geddes, 1988) in groups of two or three (Chee and 
Geddes, 1977; Geddes et ai., 1977a), which may then aggregate by disulfide bridges to form the 
large a-particles (Chee and Geddes, 1977; Geddes and Stratton, 1977b). A significant 
proportion of high molecular weight liver glycogen is compartmentalised within lysosomes 
(Geddes and Stratton, 1977a; Geddes et ai., 1983; Geddes and Taylor, 1985a,b). Apart from its 
lysosomal association, high molecular weight glycogen is also distinguished from its lower 
molecular weight counterpart by having at least double the amount of protein bound to it per 
gram of polysaccharide, even after extensive purification (Chee and Geddes, 1977; Calder and 
Geddes, 1983). 
The intralysosomal glycogen is metabolised by acid a-glucosidase (EC 3.2.1.20) which is also 
contained within the lysosome, raising the question of how it is regulated so it does not 
continually digest the lysosomal glycogen. A number of interesting experiments were carried out 
by Calder and Geddes (1989a) on the ability of acid a-glucosidase to hydrolyse glycogen 
obtained from three different sources, namely, rat liver, human placenta and oyster. The main 
difference between the glycogen from these three sources is molecular size, with rat liver being 
the largest and oyster being the smallest. Determination of V max values for hydrolysis by acid 
a-glucosidase revealed the following order of increasing activity; rat liver < human placenta < 
oyster. Earlier studies (palmer, 1971a; Matsui et aI. , 1984), gave similar results. Thus it appears 
that the rate of hydrolysis of glycogen depends largely upon the available surface area. 
Clustering of ~-particles into a-particles makes less of the surface available to enzymatic attack, 
which is the case with the majority of liver glycogen (Chee and Geddes, 1977). Conversely 
single or "split" ~-particles, such as oyster glycogen, are freely available to the enzyme (Calder 
and Geddes, 1989a). 
Kinetic analysis revealed similar Krn values for the different types of glycogen. This indicates that 
each of the glycogens bind equally well to the enzyme. Therefore, the different hydrolysis rates 
reflected in the different V max values must be due to different catalytic rates once the enzyme and 
substrate are bound. Thus the size of the glycogen molecule does not prevent enzyme binding 
but prevents enzymatic attack on glucosidic bonds, presumably by steric hindrance. Clustering 
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into a.-particles must obstruct hydrolysis by not allowing the enzyme, once bound, to attack the 
glucosidic bonds (Calder and Geddes, 1989a). 
Since lysosomal glycogen is composed mainly of protein ( disulfide) cross-linked high molecular 
weight material (Geddes and Stratton, 1977a; Geddes et al., 1983; Geddes and Taylor, 1985a,b) 
and the lysosomal acid a.-glucosidase preferentially degrades smaller glycogen, it is likely that the 
first step in lysosomal glycogen breakdown is proteolysis and/or disulfide-bond reduction. This 
would immediately make available a high concentration of low molecular weight, accessible 
glycogen (Calder and Geddes, 1989c). It is known that thiols stimulate lysosomal protein 
breakdown (Mego, 1973; Griffiths and Lloyd, 1979; Kooistra et al., 1984) and it was shown that 
this occurs only if the substrate protein contained disulfide bridges (Mego, 1984). Therefore, in 
essence, a similar role could be envisaged for cysteine in the reduction of the disulfides between 
glycogen protein backbones, perhaps concomitantly with proteolysis of the protein moieties but 
prior to hydrolysis of the carbohydrate portion of the molecule by acid a.-glucosidase (Calder and 
Geddes, 1989a). 
Studies on post-mortem glycogenolysis may give some insight into the regulatory mechanism of 
lysosomal glycogen storage and acid a.-glucosidase activity on the breakdown of lysosomal 
glycogen. After death there is a rapid loss of glycogen from the liver (Geddes and Rapson, 1973) 
and skeletal muscle (Bendall, 1973; Fischer and Hamm, 1980) with a corresponding increase in 
tissue lactate concentration (Bendall, 1973). The insufficient generation of A TP, due to the 
shortage of oxygen (Woods and Krebs, 1971; Bendall and Taylor, 1972), causes rapid 
compensatory glycogenolysis. 
The. molecular weight distributions of glycogens isolated from tissues post-mortem revealed 
marked inhomogeneity in the degradation. In percentage terms, high molecular weight glycogen 
was lost much more rapidly than low molecular weight material. The rapid loss of high 
molecular weight glycogen indicates that the lysosome is an important site for post-mortem 
degradation, since it has been shown that lysosomes of both liver and skeletal muscle are enriched 
with this material (Geddes and Stratton, 1977a; Geddes et aI., 1983; Geddes and Taylor, 
1985a,b; Calder and Geddes, 1989b). Calder and Geddes (1989a) previously proposed that the 
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size of the glycogen substrate might influence its degradation, as acid a.-glucosidase showed 
greater activity toward small glycogen molecules than towards larger material. On this basis it 
was proposed that an initial step in lysosomal glycogen degradation may be disulfide bond 
reduction and/or proteolysis. If this was the first step in post-mortem degradation then clearly 
the high molecular weight material would be reduced to low molecular weight soon after the 
onset of degradation which is observed to be the case. This suggests that as a consequence of 
post-mortem anoxia, lysosomes may become more reducing and proteolytic, and points to the 
redox potential as a possible factor regulating lysosomal function. 
A further possible regulator oflysosomal enzyme activity is pH (Calder and Geddes, 1989a). As 
glycogen is degraded, lactate is produced, lowering cellular pH. The pH of lysosomes is thought 
to be generally maintained at 1-2 units below that of the cytoplasm medium (Reijngoud et al., 
1976; Ohkuma and Poole, 1978). Therefore, as the cytosolic pH drops due to lactate 
production, the intralysosomal pH will also drop, and lysosomal acid a.-glucosidase will become 
more active (Calder and Geddes, 1989c). 
The above suggests that lysosomes may be regulated from "storage vesicles" to highly active 
"degradative vesicles", a change from one to the other occurring, for example, post-mortem. 
The "storage vesicle" is envisaged as being relatively oxidising and as containing a.-glycogen 
particles, comprised of ~-particles built on protein cores and linked via disulfide bonds. In the 
storage vesicle form, enzymes (at least the cysteine proteinases and acid a.-glucosidase) are 
relatively quiescent. By contrast, the degradative vesicle form is seen as being more reducing and 
in this glycogen is rapidly degraded via disulfide-bond reduction, and by the action of reduction-
activated proteinases and acid a.-glucosidase. 
Lysosomal glycogen storage therefore points to a varying redox potential, and pH, as two factors 
regulating lysosome function . To some extent these might work against each other, in the case 
of glycogenolysis. The reason is that the reducing strength of a given concentration of a specific 
redox pair increases with pH. F or each increase of one pH unit, Eo' becomes more negative by 
0.059 volts (Segel, 1976). With a drop in pH, therefore, the intralysosomal milieu will become 
less reducing. 
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The aim of this study was to establish whether redox potential could play any role in lysosomal 
regulation. This question was tackled from two different approaches. Firstly, to ascertain the 
effect of redox potential on lysosomal enzymes, the effect of varying concentrations of the 
reducing agent, cysteine, was tested on three lysosomal enzymes, two cysteine proteinases and 
one glycanase, which were isolated for this study. Isolated lysosomal cysteine proteinases are 
known to require reductive activation in order to manifest proteolytic activity, but the effect of 
reduction on glycanases was not known. Secondly, a method was devised for qualitatively 
detennining the redox status of lysosomes in live, cultured cells using fluorescence microscopy. 
Perfection of such a method would enable differences between different lysosomes in the same 
cell to be detennined. Also, differences between different cells, and between the same cell at 
different times, could be detennined. 
CHAPTER 2 
MATERIALS AND METHODS 
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In this chapter methods will be described that are considered fundamental , and which were used 
throughout this research project. Additionally, this chapter also contains methods which could be 
considered relatively specialized but would hinder the intended structure of the relevant chapter. 
Detail has been afforded to methods where results can be either ambiguous or deceptive. In this 
chapter only reagents that were prepared before use are described, reagents that were used "as-
is" are referred to at the relevant point in the procedure section. 
2.1 Materials 
Most of the common chemicals used in this study were from BDH, Merck or Boehringer Mannheim, 
and were ofthe highest purity available. Coomassie brilliant blue R-2S0 was from Merck. Acrylamide; 
N,N-methylenebisacrylamide; and N,N,N ,N-tetramethylethylenediamine (TEMED) were from BDH. 
Dialysis tubing, 7 -amino-4-methyl coumarin, dithiothreitol (OTT), L-trans-epoxysuccinyl-
leucylamido( 4-guanidino )butane (E-64), S-Sepharose, Sephacryl S-100 and Sephadex G-I00 were 
from Sigma Chemical Co., St. Louis, Mo. USA. 2,2 Azino-di-(3-ethyl) benzthiozoline sulphonic acid 
(ABTS) was from Boehringer Mannheim, SA. Bz-Phe-Val-Arg-NHMec, 4-methylumbelliferyl-a-
glucoside, 4-methylumbelliferone, Z-Phe-Arg-NHMec and Z-Arg-Arg-NHMec were from 
Cambridge Research Chemicals, UK. ELISA plates were Nunc-Immuno Maxisorp F96 plates from 
Weil Organisation, SA. Freund' s complete and incomplete adjuvants were from Difco, Mi., USA. 
2.2 Protein assays 
Protein purification procedures requrre methods of protein quantItatIon which are specific, 
reproducible, and preferably rapid, using small amounts of sample. The protein assay used in the 
present study was the Bradford dye-binding assay (Bradford, 1976), as modified by Read and 
Northcote (1981). 
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2.2.1 Bradford dye-binding assay 
The Bradford dye-binding assay was instituted as a rapid, sensitive, reproducible and inexpensive 
technique for protein quantitation, which is free of interference from most commonly used chemicals 
(Bradford, 1976). 
The Coomassie brilliant blue G-250 dye exists in two forms: a cationic red form, which is present in 
the acidic solution of the Bradford reagent, and the anionic blue form. The former has an absorption 
maximum at 465 nm, while the latter absorbs maximally at 595 nm. The red form is converted to the 
blue form upon binding to protein, and the consequent shift in absorption maximum allows the 
spectrophotometric quantification of protein. At 595 nm the extinction coefficient of the blue protein-
dye complex is far greater than that of the unbound dye, and allows for high sensitivity in protein 
quantification. 
A major advantage of the technique is the lack of interference by most commonly used chemicals. The 
effects of small amounts (less than 1 %) of Tris, acetic acid, sucrose, glycerol, ethylene diamine tetra-
acetic acid (EDTA), Triton X-lOO and sodium dodecyl sulfate (SDS) can be eliminated using an 
appropriate buffer blank. The potential interference caused by detergents at concentrations of 1 % or 
greater, however, requires their removal prior to assaying. 
The greatest disadvantage of the dye-binding assay is the wide variation in the dye-binding of different 
proteins. Extrapolation of values from standard curves to other proteins may therefore be inaccurate. 
To minimise such variation, Read and Northcote (1981) modified the acid/alcohol ratios in the assay 
solution and increased the dye concentration, using the purer Serva blue G dye. Pike (1990), 
however, found that under such conditions the dye precipitated over long periods, but that substitution 
of the dye alone sufficiently diminished variations in dye-binding. The only disadvantage of this 
reagent, compared to that of Read and Northcote (1981), was a non-linear response at higher protein 
levels (beyond 5 Jlg in the micro-assay procedure). 
Two protein assays have been established: a macro-assay with a working range of 5-25 Jlg of protein 
(Bradford, 1976), and a micro-assay for the determination of 1-5 Jlg of protein (Read and Northcote, 
1981). In the present study only the micro-assay was used. 
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2.2.1.1 Reagents 
Dye reagent. Serva blue G dye (50 mg) was dissolved in 88% phosphoric acid (50 ml) and 99.5% 
ethanol (23.5 ml). The solution was made up to 500 ml with dist.H:zO and stirred for 30 min. The 
resulting solution was filtered through Whatman No. 1 filter paper and stored in an amber coloured 
bottle. Visual checks for precipitation were made prior to use, and if precipitation was observed, hte 
reagent was filtered and re-calibrated or a new batch was made up. 
Standard protein solution. A 0.1 mglml ovalbumin solution was made up in dist.H:zO. 
2.2.1.2 Procedure 
Samples were diluted to 50 I.ll with dist.H:zO, dye reagent (950 JJ1) was added, and the solution was 
mixed and allowed to stand for 2 min for colour development. The absorbance was read at 595 nm 
against appropriate blanks. Plastic microcuvettes (1 ml) were used, as the dye reagent binds to glass 
(Bradford, 1976). The blue stain which developed on the plastic cuvettes could be easily removed 
with diluted sodium hypochlorite. A standard curve, from 0-50 JJ1 (0-5 Ilg) of the standard protein 
solution was constructed. Results for protein assays were calculated from the equation: 
y = 0.0398x + 4.8 x 10-3 
generated by linear regression analysis of the standard curve data. 
2.3 Concentration of samples by dialysis against sucrose or polyethylene glycol 
It was often necessary to concentrate dilute protein samples, before subjecting them either to further 
purification, SDS-PAGE analysis or for inoculation procedures. Samples were concentrated by 
dialysis, in dialysis tubing with a M cut-off of 12000, against sucrose or polyethylene glycol (pEG), 
which have high osmotic pressures when in solution. A concentration gradient is established between 
the solvent (water) in the dialysis bag, and the solute (sucrose or PEG) at the exterior surface of the 
membrane. Water and buffer ions will slowly move out of the dialysis bag, progressively dissolving 
the solute, while proteins larger than the membrane molecular cut-off limit are retained in the bag. The 
protein solution will therefore be concentrated. 
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Sucrose, which is inexpensive, was often used but a disadvantage is that it is small enough to diffuse 
into the dialysis bag. High levels of sucrose in a sample may interfere with certain assays or 
applications. When sucrose-free samples were required, they were dialysed against PEG (Me 20 000). 
The molecular weight of PEG is greater than the cut-offlimit of the dialysis membrane, and thus PEG 
will not move into the sample. 
2.4 Electrophoretic techniques 
2.4.1 Tris-glycine SDS-PAGE 
Electrophoresis describes the migration of a charged particle under the influence of an electric field. 
For bands to be well resolved the starting band of sample must be as thin as possible, and the diffusion 
of the protein bands in the gel must be minimised. For these reasons Ornstein (1964) and Davis 
(1964) developed a discontinuous system, using polyacrylamide gels with consistent, defined 
porosities. 
The Ornstein-Davis system makes use of two different buffer systems, and two different gel 
porosities. The sample and stacking gel contain a Tris-HCI buffer, while the electrode buffers are 
Tris-glycine. At the pH of the sample and stacking gel (PH 6.8), glycine is poorly dissociated and has 
a small negative charge and hence low mobility. The chloride ions in the sample and stacking gel have 
a higher mobility at pH 6.8, while the proteins have a mobility intermediate between the two ions. 
When an electrical potential is applied, the glycine (trailing) and chloride (leading) ions will generate 
and maintain a sharp interface. The voltage gradient in front of the interface is low, in contrast to the 
steeper voltage gradient behind the interface. Proteins in the lower voltage gradient have lower 
mobility than the chloride ions, whereas any protein in the higher voltage gradient will have a higher 
mobility than the glycine ions. Consequently all proteins will stack at a sharp interface between the 
leading and trailing ions. The large pore stacking gel has no molecular sieving effects, but serves to 
protect the sample from convective disturbances during stacking. 
When the protein stack reaches the resolving gel, the increased pH of the resolving gel causes 
increased dissociation, and hence increased mobility, of glycine ions. The glycine ions overtake the 
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proteins, and fonn a front with the chloride ions and tracking dye. The destacked proteins are left to 
migrate in a unifonn voltage gradient at a constant pH. The pore size of the resolving gel is smaller 
than that -of the stacking gel, and hence molecular sieving of the proteins occurs. Proteins are 
therefore separated on the basis of their size, shape and intrinsic charge at the pH of the resolving gel. 
Although PAGE (polyacrylamide gel electrophoresis) is useful for the separation of proteins on the 
basis of charge and size and for the determination of protein forms, which may vary as a result of 
phosphorylation, glycosylation, truncation, or by the fonnation of disulfides, this technique is limited in 
not identifying proteins solely according to MW. For this reason SDS (sodium dodecyl sulfate)-
PAGE was devloped. The anionic detergent, SDS, binds to proteins at a constant ratio of 1.4 g SDS 
per gram protein (Reynolds and Tanford, 1970). The charge of SDS, bound to protein, is sufficient to 
mask the charge on the protein such that all SDS-protein complexes have the same charge to mass 
ratio. Proteins of different MW can therefore be separated on the basis of size alone following binding 
of SDS and SDS-P AGE. The principles ofP AGE still apply, and hence the same buffering systems as 
described by Ornstein (1964) and Davis (1964), can be applied to SDS-PAGE (Laemmli, 1970). 
The boiling of samples in the presence of SDS and reducing agent, prior to SDS-P AGE, ensures the 
reduction of disulfide bridges in proteins and complete protein denaturation and saturation with SDS. 
Non-reducing SDS-P AGE can, however, be used to detect protein complexes or oligomers. A 
number of factors may cause the anomalous migration of proteins on SDS-P AGE. The variable glyco 
moieties of glycoproteins do not bind SDS, and may be responsible for micro heterogeneity of bands 
observed on SDS-PAGE (Hames, 1981). Very basic proteins may repress the overall negative charge 
of the SDS-protein complex., and consequently migrate to anomalous M values (Hames, 1981). 
For the estimation ofM values, the mobilities of the electrophoresis standard proteins relative to the 
mobility of the bromophenol blue tracking dye were calculated, and expressed as Rc values. A 
standard curve was constructed by plotting log MW of the standard proteins against their Rc values, 
from which the M of the sample proteins could be calculated. 
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2.4.1.1 Reagents 
Solution A: monomer solution [30% (mlv) acrylamide. 2.7% (mlv) bis-acrylamide]. Acrylamide 
(73 g) and bis-acrylamide (2 g) were dissolved and made up to 250 ml with dist.H20 and stored in an 
amber coloured bottle at 4°C. 
Solution B: 4 x running gel buffer [l.5 M Tris-HCl. pH 8.8]. Tris (45.37 g) was dissolved in 
approximately 200 ml of dist.H~, adjusted to pH 8.8 with HCI, and made up to 250 ml. 
Solution C: 4 x stacking gel buffer [500 mM Tris-HCI, pH 6.8]. Tris base (3 g) was dissolved in 
40 ml dist .H~, adjusted to pH 6.8 with HC~ and made up to 50 ml. 
Solutions A, B, and C were filtered through Whatman No. 1 filter paper before use. 
Solution D: 10% (mlv) SDS. SDS (10 g) was dissolved in 100 ml dist .H~ with gentle heating if 
necessary. 
Solution E: Initiator [10% (mlv) ammonium persulfate]. Ammonium persulfate (0.2 g) was made up 
to 2 ml with dist.H20 just before use. 
Solution F: tank buffer [250 mM Tris-HCI, 192 mM glycine, O.l% (mlv) SDS, pH 8.3]. Tris (15 g) 
and glycine (72 g) were dissolved and made up to 5litres with dist.H~. Prior to use, 2.5 ml of SDS 
stock (solution E) was added to 250 ml. 
Solution G: reducing treatment buffer [125 mM Tris-HCI, 4% (m/v) SDS, 20% (v/v) glycerol, 
10% (v/v) 2-mercaptoethanoL pH 6.8]. Buffer C (2.5 ml), glycerol (2 ml), 10% SDS (4 ml) (solution 
D) and 2-mercaptoethanol (1 ml) were made up to 10 ml with dist.H~. Aliquots (1 ml) were frozen 
and stored for no longer than 3 months. 
Molecular weight markers: [1 mg standard protein/ml]. Standards for Mr determination were: 
lysozyme (MW 14000), carbonic anhydrase (MW 29000), ovalbumin (MW 45 000), bovine serum 
albumin (MW 68 000) and phosphorylase b (MW 97 400). A solution containing 1 mg of each of the 
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standard proteins in dist.H20 was mixed with treatment buffer (1 ml) containing 0.005% (m/v) 
bromophenol blue tracking dye. 
Stain stock solution [1% (m/v) Coomassie blue R-250]. Coomassie blue R-250 (1 g) was dissolved 
in 100 ml of dist.H20 by magnetic stirring for 1 h at room temperature. The solution was filtered 
through Whatman No. 1 filter paper. 
Stain solution [0.125% (m/v) Coomassie blue R-250. 50% (v/v) methanol 10% (v/v) acetic acid]. 
Stain stock (62.5 ml) was mixed with methanol (250 ml) and acetic acid (50 ml), and made up to 
500 ml with dist.H~. 
Destaining solution I [50% (v/v) methanol, 10% (v/v) acetic acid]. Methanol (500 ml) was mixed 
with acetic acid (100 ml) and made up to 1 litre with dist.H~ 
Destaining solution II [7% (v/v) acetic acid, 5% (v/v) methanol]. Acetic acid (70 ml) was mixed with 
methanol (50 ml), and made up to 1 litre with dist.H~. 
2.4.1.2 Procedure 
Table 1. Preparation of resolving and stacking gels for Tris-glycine SDS-P AGE 
Reagent Running Gel (%) Stackinggel(%) 
12.5% 7.5% 4% 
Acrylamide (A) 6.25 ml 3.75 ml 0.94 ml 
Running gel buffer (B) 3.75 ml 3.75 ml 
Stacking gel buffer (C) 1.75 ml 
10% SDS (D) 0. 15 ml 0.15 ml 70 j..d 
dist.H20 4.75 ml 7.25 ml 4.20 ml 
Ammonium persulfate (E) 75 III 75 III 35 III 
TEMED 7.5 III 7.5 III 18 III 
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For SDS-PAGE, the Hoefer SE 250 Mighty Small IT vertical slab electrophoresis unit was assembled 
as described in the manufacturer' s manual. Before use the notched aluminium plate and glass plate 
were thoroughly cleaned and clamped together using 1:5 mm polyethylene spacers to separate them at 
the edges. Molten 1 % agarose was used to plug the bottom of the sandwich chamber before the 
running gel solution was poured into the space between the plates to a depth 3 em from the top of the 
glass plate. The gel was overlaid with dist.H20, to exclude atmospheric oxygen which prevents 
polymerisation. Once the gel has set (appearance of interface between gel solution and water, usually 
about 1 h), the water was removed by inversion. Stacking gel solution was poured in, up to the notch 
in the aluminium plate, and a lOwell comb was inserted to form the sample application wells. Once 
the gel had set (about 30 min) the comb was removed and the wells were rinsed with dist.H20 . 
Tank buffer, containing SDS, was poured into the upper and lower electrode compartments. The 
samples for reducing SDS-P AGE were combined with an equal volume of reducing treatment buffer 
(solution G) and incubated in a boiling water bath for 90 s, before being placed on ice until they were 
loaded onto the gel. A marker dye, bromophenol blue (5 ~), which migrates with the buffer front, 
was added to each sample before loading onto the gels. Samples were applied into the wells, using a 
Hamilton micro syringe, at a concentration of at least 1 Ilg per band for Coomassie blue R-250, and 
250 ng per band for silver staining. The gel was connected to a power pack and run at 18 rnA per gel 
until the bromophenol blue tracker dye was about 0.5 cm from the bottom of the running gel. The gel 
was then disconnected from the power supply, and the plates removed. The gels were removed and 
placed in Coomassie blue R-250 staining solution for 4 h. Following rinsing with dist.H20, the gel 
was placed into destain I overnight and then into destain IT to effect complete destaining. Gels were 
stored in polythene zip-seal bags and kept well hydrated until photographed. 
2.4.2 Tris-Tricine SDS-PAGE 
Small proteins and peptides form complexes with SDS of similar size and charge as the SDS micelles, 
which run at the buffer front on SDS-P AGE (Fish et aI. , 1970). Such proteins (M. < 10 000) 
therefore migrate with the buffer front and are not resolved by conventional Tris-glycine SDS-P AGE. 
By decreasing the mobility of protein relative to the trailing ion, using a higher pH and Tricine as a 
trailing ion in the stacking phase, Schagger and von Jagow (1987) were able to resolve lower MW 
proteins from the SDS micelles. Using this system with the recommended three sets of gel porosities, 
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separation of proteins of MW 1 000 - 100 000 can be achieved on a single gel (Schagger and von 
Jagow, 1987). 
2.4.2~1 Reagents 
Monomer solution: [49.5% (m/v) aClYlamide, 3% (m/v) N,N' -methylene-bisaClYlamide]. Acrylamide 
(120.0 g) and N,N' -methylene-bisacrylamide (3 .8 g) were dissolved in dist.H~ and made up to 
250 ml. Storage was at 4°C in the dark. 
Gel buffer: [3 M Tris-HCl. 0.3% (m/v) SDS, pH 8.45]. Tris (90.83 g) was dissolved in 200 ml 
dist.H20 , and adjusted to pH 8.45 with HCl. 10% (m/v) SDS (7.5 ml) (Section 2.4.1.1) was added 
and the solution was made up to 250 ml. 
Anode buffer: [0.2 M. Tris-HCl pH 8.9]. Tris (24.22 g) was dissolved in 950 ml of dist.H~, 
adjusted to pH 8.9 with HC~ and made up to 1 litre. 
Cathode buffer: [0.1 M Tris-HCl 0.1 M Tricine, 0.1 % (m/v) SDS, pH 8.25]. Tris (12.11 g), Tricine 
(17.92 g) and 10% (m/v) SDS (10 ml) were made up to 1 litre with dist.H~ and the pH checked. 
Treatment buffer: [125 mM Tris-HCI, 4% (m/v) SDS, 20% (v/v) glycerol, 10% (v/v) 
2-mercaptoethanol, 0.01% (m/v) Serva blue G, pH 6.8]. Stacking gel buffer (2.5 ml), glycerol (2 ml) 
10% (m/v), SDS (4 ml) and 2-mercaptoethanol (1 ml) were made up to 10 ml with dist.H20. Serva 
blue G tracking dye [0.01% (m/v)] was added. For non-reducing SDS-PAGE, 2-mercaptoethanol 
was omitted. 
Other reagents were as described in Section 2.4.1.1. 
2.4.2.2 Procedure 
The procedure for SDS-P AGE (Section 2.4 .1.2) was modified in the composition of the resolving and 
stacking gels as described in Table 2. The gels were run at 200 V with unlimited rnA, and stopped 
when the Serva blue dye reached the bottom of the gel. The gels were stained as described in Section 
2.4.1.2 or Section 2.5. 
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Table 2. Preparation of resolving and stacking gels for Tris-Tricine SDS-PAGE 
Reagents Resolving Gel Stacking Gel 
10%T, 3%C 4%T, 3%C 
Monomer (49.5% T, 3% C) 3ml 1.5 ml 
Gel buffer 5ml 0.5 ml 
dist.H2O 14.95 ml 6.22 ml 
Ammonium persulfate 50 J.!l 3OI·d 
TEMED 8J.!l l21l1 
2.5 Silver staining of electrophoretic gels 
A number of techniques utilise the specific chemical reduction of silver to detect protein in 
electrophoretic gels. The sensitivity of such techniques is comparable to that of autoradiography, in 
detecting nanogram amounts of proteins (Nielson and Brown, 1983). 
In the presence of a reducing agent, and at high pH values, silver ions form insoluble, coloured 
complexes with charged amino acid side chains (Nielsen and Brown, 1983). However, the pH 
change, required by most silver staining procedures, causes the non-specific formation of insoluble 
silver salts on the gel, thereby impairing contrast (Blum et al., 1987). By treating the gel with sodium 
thiosulfate, which complexes to and dissolves silver salts, Blum et af. (1987) found that the levels of 
background staining could be reduced. Using this technique, greater contrast could be achieved 
without impairing the high sensitivity of staining. 
2.5.1 Reagents 
Fixing solution: [50% (v/v) methanol. 12% (v/v) acetic acid, 0.2% (v/v) formaldehyde]. Methanol 
(100 ml), glacial acetic acid (24 ml) and 37% formaldehyde (0.1 ml) were made up to 200 ml with 
dist.H20 . 
Wash solution: [50% (v/v) ethanol]. Ethanol (100 ml) was made up to 200 ml with 200 ml dist.H20 . 
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Pre-treatment solution: [0.02% em/v) Na§ihSH20]. Na2S03.SH20 (0.1 g) was made up to 500 ml 
with dist.H20 . 
Impregnation solution: [0.2% em/v) AgN03, 0.03% (m/v) formaldehyde]. AgN0J (0.4 g) and 37% 
formaldehyde (0.15 ml) were made up to 500 ml with dist.H20 . 
Development solution: [6% em/v) Na£03, 0.0004% (m/v) Na2SA·5H20, 0.02% (v/v) 
formaldehyde]. Na;£03 (12 g), pre-treatment solution (4 ml) and 37% formaldehyde (0.1 ml) were 
made up to 200 ml with dist.H~ . 
Stop solution: [50% ev/v) methanol, 12% (v/v) acetic acid]. Methanol (50 ml) and glacial acetic acid 
(12 ml) were made up to 100 ml with dist .H~. 
2.5.2 Procedure 
All steps were carried out on a shaker, at RT and in clean glass containers. After electrophoresis, the 
gel was soaked in fixing solution (1 h), and wash solution (3 x 20 min) to neutralise the gel and allow 
for subsequent treatment with the acid labile Na2S20 3. The gel was treated with pre-treatment 
solution (1 min), rinsed with dist.H20 (3 x 20 s), and soaked in impregnation solution (20 min). After 
rinsing with dist.H20 (3 x 20 s), to remove excess AgN03 from the gel surface, the gel was immersed 
in development solution until bands were evident against a lightly stained background «10 min). The 
gel was rinsed in dist.H20 (2 x 2 min), treated with stop solution (10 min), and stored in a sealed 
plastic bag, in the dark, until photographed. 
2.6 Protein fractionation using three phase partitioning (TPP) 
Protein folding and protein solubility are dependent on hydration, and hence agents which change the 
properties of water can affect folding and precipitation. Kosmotropic agents tend to promote the 
structure of water, whereas chaotropic agents disrupt the structure of water. The kosmotropes, 
sulfate and t-butanol, cause the ordering of water molecules solvating them, thereby minimising the 
surface area of any protein in the solution, and stabilising the protein. Tertiary butanol, which is 
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completely miscible with water, forms a separate phase upon the addition of sufficient ammonium 
sulfate. In addition, any protein present in the aqueous phase may precipitate out, depending on the 
concentration of ammonium sulfate, due to hydration effects. Three phases are therefore formed: a 
lower aqueous phase, an upper t-butanol phase, and an interfacial t-butanolated protein phase (pike 
and Dennnison, 1989; Dennison et al., 1996). 
Since kosmotropes tend to tighten and stabilise protein conformations, the proteins are precipitated in 
a protected form (Dennison et aI., 1996). However, multimeric proteins in which the subunits are 
linked by disulfide bonds, such as haemoglobin, tend to be denatured by the TPP process (pike and 
Dennison, 1989). TPP has an additional advantage in removing contaminants which are soluble in 
organic solvents, such as lipids, phenolics and pigments, into the t-butanol phase. Furthermore, TPP 
derived protein precipitates contain low levels of salts and t-butanoL and once redissolved in an 
appropriate buffer, can be applied directly to ion exchange chromatography columns. TPP has been 
found to be superior to conventional ammonium sulfate precipitation in the isolation of a number of 
proteinases in this laboratory. These include cathepsin L (pike and Dennison, 1989), cathepsin D 
(Jacobs et aI., 1989) and trypanosome proteinases (Troeberg et aI., 1996). In the present study, TPP 
was utilised during the purification of porcine liver acid a-glucosidase, and bovine spleen cathepsins S 
andB. 
TPP was effected by the addition and mixing in of 2-methylpropan-2-o1 (t-butanol) to 30% 
(v/v offinal volume). 
The volume of t-butanol to be added was calculated as follows: 
x 
--= 0.3 x+y 
where x = volume of t-butanol 
y = volume of pH 4.2 supernatant 
The t-butanol was first warmed to 30°C (above its crystallisation temperature of about 250C). 
Solid <NH4hS04 (% (mlv) based on the volume of the pH 4.2 supernatant and t-butanol) was 
dissolved with stirring. The mixture was centrifuged (8000 x g, 10 min, 4°C) in a swing-out 
rotor and the supernatant t-butanol and subnatant aqueous phases decanted, leaving behind the 
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third phase of interfacial protein precipitate which was discarded. Further (NR.)2S04 was added 
to the aqueous and solvent phases to bring the concentration to a % (m/v) (based on the volume 
of pH 4.2 supernatan~ and t-butanol) and was dissolved with stirring. The solution was again 
centrifuged as before and the interfacial protein layer collected by decanting the super- and 
subnatants. The precipitate was redissolved in an appropriate buffer at approximately one-tenth 
of the volume of the acid supernatant. The solution was centrifuged (15 000 x g, 10 min, 4°C) 
and filtered through Whatman No. 4 filter paper to remove undissolved protein. 
2.7 Hydroxyapatite chromatography 
Crystalline calcium hydroxyphosphate, [CaS(P04)3(OH)h, is known as hydroxyapatite, or 
hydroxylapatite (GorbuotT, 1985), and its particular usefulness in protein isolations is that it binds 
proteins by a unique mechanism, different from MEC and simple ion-exchange, and it can 
therefore separate proteins which may not be separable by other means (Bernardi, 1971 ; 1973; 
GorbuotT, 1985). Hydroxyapatite forms blade-like crystals and because the protein binds to the 
surface of the crystals, rather than within a gel lattice, the protein binding capacity is relatively 
low. For this reason, hydroxyapatite is best suited for use as one of the final steps in a 
purification. 
Blade shaped crystals are not optimal for chromatography and they tend to be brittle, thus 
generating "fines" which block the column and limit its life to three or four runs. Several 
manufacturers have attempted to overcome this by making spherical forms of hydroxyapatite, 
e.g. macro-prep ceramic hydroxyapatite from Bio-Rad and HA ultragel from Pharmacia. 
However, if the hydroxyapatite is used at the end of a purification, the fact that the classical 
crystals have a limited life is oflesser consequence. 
2.7.1 The mechanism of hydroxyapatite chromatography 
The separating mechanism of hydroxyapatite is summarised in reviews by Gorbunoff (1985) and 
by Dennison (pers. comm.). Hydroxyapatite crystals have positive surface charges, due to their 
constituent calcium ions, and negative charges due to their phosphate groups. The net charge 
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can be varied by the buffer - it is negative in phosphate buffer, neutral in NaCI and positive in 
CaCh or MgCh. 
Positive ammo groups of proteins bind electrostatically to negative charges on the 
hydroxyapatite, and are thus influenced by net charge. 
Hydroxyapatite - P04- ·· ··· · ··H3~ - Protein 
Negative carboxyl groups, on the other hand, bind by complexing with calcium 10 the 
hydroxyapatite. 
Hydroxyapatite - Ca - OOC - Protein 
The retention of acidic (negatively charged) proteins is thus affected by the net charge on the 
hydroxyapatite in a manner opposite to that of basic (positively charged) proteins. CaCh and 
MgCh increase the binding of acidic proteins by the formation of salt bridges between protein 
carboxyl groups and hydroxyapatite phosphate sites. 
Hydroxyapatite - P04- .. .... .. -OOC - Protein 
Basic proteins may be eluted from hydroxyapatite by negative ions such as F , cr, and HPOl, 
which compete with its negative phosphate sites, or by Ca2+ or Mg2+ ions, which specifically 
complex with its phosphate sites and neutralise their charges. Acidic (negative) proteins may be 
eluted by displacement of their carboxyl groups from hydroxyapatite complexing sites by ions, 
such as phosphate or F , which form stronger complexes with calcium. 
Most proteins contain both amino and carboxyl groups and phosphate is effective in eluting both 
types. Consequently, a common means of eluting proteins from hydroxyapatite is by the 
application of a phosphate gradient - often K-phosphate, because Na-phosphate has limited 
solubility at low temperatures. Gorbunoff (1985) discussed alternative approaches, where the 
effects of CaCh and MgCh, and NaCI and KCI, can additionally be exploited in elution schemes. 
As previously mentioned, using this procedure, separations may be achieved which are not 
possible using other chromatographic systems and hydroxyapatite is thus a valuable technique. 
2.8 Generation and isolation of antibodies 
Antibodies were raised in rabbits following inoculation with antigen emulsified with an adjuvant. 
The adjuvant facilitates the slow release of antigen as the emulsion breaks down, and hence 
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prolongs the exposure of the antigen to the immune system of the experimental animal. The 
initial inoculation was with the antigen emulsified with Freund' s complete adjuvant, which 
contains killed Mycobacterium tuberculosis cells in order to enhance the primary immune 
response by attracting neutrophils and macrophages to the inoculation site. In subsequent 
inoculations, the antigen of interest was emulsified with Freund' s incomplete adjuvant to further 
stimulate the selected B-cell clone, which produces antibodies specific to the antigen. Rabbits 
were inoculated at 2, 4, 8, and 12 weeks after the first inoculation, to ensure high levels of 
specific antibody production. 
IgG may be purified from serum by a simple and convenient method that makes use of the protein 
precipitating properties of polyethylene glycol (pEG), a water soluble polymer (polson et aI. , 1964). 
Polyethylene glycol is a mild precipitating agent which operates on a steric exclusion mechanism, 
whereby proteins are concentrated in the extrapolymer space, until they exceed their solubility limit. It 
was found that the concentration of the polymer required to precipitate a protein is a function of the 
charge of the protein, and hence is dependent on the pH of the protein solution (polson et aI. , 1964). 
The protocol used to purifY IgG from rabbit serum was that of Polson et al. (1964). 
2.8.1 Reagents 
Borate buffered saline, pH 8.6. A sodium borate solution was prepared by dissolving boric acid 
(2.16 g), NaCI (2.19 g), NaOH (0.7 g) and 37% HCI (0.62 mI) in 950 mI dist.Hi), checking and 
adjusting the pH if necessary with HCI or NaOH, and making the solution up to 1 litre. 
100 mM Na-phosphate buffer. 0.02% (m/v) NaN), pH 7.6. NaH2P04.Hi) (13 .8 g) and NaN3 (0.2 g) 
were dissolved in 950 mI of dist.H20 , titrated to pH 7.6 using NaOH, and made up to 1 litre. 
2.8.2 Procedure for the isolation of IgG from rabbit serum 
Rabbits were bled from the marginal ear vein into scrupulously clean, dry, 10 mI test glass tubes, 
and the blood was allowed to clot overnight at 4°C. The serum was drawn off the clot and 
diluted 1:2 with borate buffer. Solid polyethylene glycol (Mr 6 000) was added to the diluted 
serum to 14% (m/v), dissolved by gentle stirring, and the solution was centrifuged (12 000 x g, 
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10 min, RT). The pellet was redissolved in the original serum volume of sodium phosphate 
buffer. PEG was once more added to a concentration of 14% (m/v), dissolved, and centrifuged 
(12000 x g, 10 min, RT). The pellet was redissolved in half the initial serum volume of sodium 
phosphate buffer containing 60% glycerol, and stored at -20°C. The A280 of a 1:40 dilution of 
IgG solution in 100 mM phosphate buffer was determined and the concentration of IgG in the 
undiluted solution was calculated [extinction coefficient of IgG, E280 (1 mglml) = l.43 (Hudson 
and Hay, 1980)]. 
2.9 Enzyme Linked Immunosorbent Assay (ELISA) 
Immunoassays use the specific interaction of an antibody with an antigen to provide information about 
antibody or antigen concentrations in unknown samples. In principle, the labelling by chemical 
conjugation of an enzyme to either antibody or antigen allows the detection of immune complexes 
formed on a solid phase. This forms the basis of the enzyme-linked immunosorbent assay (ELISA), 
first introduced by Engvall and Perlmann (1971). One of the simplest and most commonly used 
ELISAs, for the detection of antibodies, is a three layer system. Briefly, antigen is coated to the plastic 
surface of the wells of polystyrene microtitre plates, and the primary antibodies to be quantified 
allowed to form a complex with the immobilised antigen. After excess antibody has been washed 
away, the degree or amount of reactivity is quantified with an appropriate detection system. In an 
ELISA this takes the form of an enzyme conjugated to a secondary antibody which will recognise the 
primary antibody bound to the immobilised antigen. The enzyme reacts with a substrate which yields a 
coloured product which can be measured spectrophotometrically. 
During the course of this work, an ELISA was used to evaluate the progress of polyclonal antibody 
production during the immunisation of rabbits with bovine liver acid a-glucosidase. 
2.9.1 Reagents 
Phosphate buffered saline (PBS). pH 7.2. NaCI (8 g), KCI (0.2 g), Na2HP04.2H20 (l.15 g) and 
KH2P04 were dissolved in 1 litre of dist.H20 . 
0.5% em/v) Bovine serum albumin-PBS (BSA-PBS). BSA (0.5 g) was dissolved in 100 ml of PBS. 
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0.1% PBS-Tween. Tween 20 (1 ml) was made up to 1 litre in PBS. 
0.15 M citrate-phosphate buffer, pH 5.0. A solution of citric acid .H~ (2l.0 gil) was titrated with a 
solution ofNa2HP04.2H~ (35.6 gil) to pH 5.0. 
Substrate solution [0.05% (m/v) 2,2'-azino-di-(3-ethyl)-benzthiozoline sulphonic acid (ABTS) and 
0.0015% (v/v) Hil2 in citrate-pho~hate buffer]. ABTS (7.5 mg) and H~ (7.5 ~) were dissolved in 
citrate-phosphate buffer, pH 5.0 (15 ml), for one ELISA plate. 
Stopping buffer (citrate-pho~hate-O . l% (m/v) NaN,3). NaN3 (0.1 g) was made up to 100 ml in 
citrate-phosphate buffer. 
Carbonate coating buffer. NaHC03 (0.21 g) was dissolved in 45 ml of dist.H~, titrated to pH 6.0 
with HCl , and made up to 50 ml. 
2.9.2 Procedure 
Wells of micro titre plates (Nunc Immunoplate) were coated with antigen (150 ~) at a predetermined 
dilution (1 Ilg/ml as determined by a checkerboard ELISA) in PBS overnight at room temperature. 
Wells were blocked with BSA-PBS (200 ~) for 1 h at 37°C and washed 3 times with PBS-Tween. 
Serial two fold dilutions of the primary rabbit antiserum in BSA-PBS (1 mg/ml) was added (100 ~), 
incubated for 1 h at 37°C and excess antibody washed out 3 times with PBS-Tween. A 1:500 dilution 
of sheep anti-rabbit IgG-horseradish peroxidase (HRPO) conjugate in BSA-PBS, was added (120 ~) 
and incubated for 1 h at 37°C. The ABTS substrate (150 ~) was added and incubated in the dark for 
optimal colour development (usually 10-20 min). The enzyme reaction was stopped by the addition of 
50 III of 0.1% (m/v) NaN3 in citrate-phosphate buffer and the absorbance read at 405 nm in a Bio-Tek 
EL307 ELISA plate reader. Titration curVes were constructed from the spectrophotometric values. 
. CHAPTER 3 
ISOLATION OF THREE LYSOSOMAL ENZYMES, 
CATHEPSINS SAND B AND ACID a-GLUCOSIDASE 
3.1 Introduction 
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Lysosomes, which are membrane-bound intracellular organelles, have important functions in 
mammalian cells under physiological as well as pathological conditions. The lysosomes contain 
many different enzymes, mostly acid hydrolases. Collectively, these enzymes are capable of 
degrading virtually all large cellular molecules, such as nucleic acids, proteins, polysaccharides, 
and lipids, to low molecular weight products. In this study attention will be focused on the 
lysosomal proteinases, especially cathepsins S and B, and the enzyme responsible for digestion of 
lysosomal glycogen, acid a.-glucosidase. 
Proteinases are classified into two groups, endo- and exopeptidases, according to their 
proteolytic cleavage sites. They are further subclassified into four groups, the serine, cysteine, 
aspartic, and metalloproteinases, based on groups constituting the active site. In some highly 
specialised cells, such as leukocytes, serine- and metalloproteinases have been demonstrated, but 
cysteine and aspartic proteinases are ubiquitously present in the lysosomes of various tissue cells. 
Lysosomal cathepsins B, C, H, Land S are cysteine proteinases and cathepsin D is an aspartic 
proteinase. Proteolytic enzymes have a variety of biological functions ranging from peptide 
biosynthesis to protein degradation. Cysteine proteinases have been implicated in many diverse 
cellular events, including receptor internalisation, protein turnover, neuronal degradation and 
regeneration during development, and antigen processing (Katunuma and Kominami, 1983; Bond 
and Butler, 1987). They have also been proposed to be involved in selective cleavage of protein 
precursors to release regulatory peptides (Devi, 1991). Since cysteine proteinases play a vital 
role in nonnal cellular protein metabolism, it is understandable that they have also been 
implicated in a number of disease states, including cancer, arthritis, and Alzheimer' s disease 
(Katunuma and Korninarni, 1983; Tryggvason et aI. , 1987; Golde et aI. , 1992). 
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The mammalian lysosomal cysteine proteinases cathepsins B [EC 3.4.22.1], H [EC 3.4.22.16], 
L [EC 3.4.22.15] and S [EC 3.4.22.27] belong to the group of closely related proteins of the 
papain superfamily (Barrett, 1986). These enzymes are considered to play an important role in 
the initial or terminal stages of protein degradation (Bond and Butler, 1987). Whereas cathepsins 
B, H, and L have been extensively studied (Takio et ai., 1983; Ritonja et ai., 1985, 1988; Meloun 
et ai., 1988), there is still limited knowledge about cathepsin S. 
Acid a-glucosidase is a 'Y-amylase with specificity for glycogen and several natural and synthetic 
oligo glue os ides (Hoefsloot et aI., 1988). Its importance in lysosomal glycogen turnover has been 
emphasised by the lysosomal glycogen storage disease glucogenosis type II (Pompe's disease), an 
autosomal recessive disease, where a deficiency of lysosomal acid a-glucosidase causes an 
accumulation of glycogen in lysosomes (Hers, 1963). 
This chapter describes the isolation of the three lysosomal enzymes cathepsins S, B and acid 
a-glucosidase. The aim was to streamline the currently known isolation procedures for these 
three enzymes to make it simple and cost effective to obtain them for studies described in 
Chapter 4. Cathepsin S, the least studied of these enzymes, was further characterized to obtain 
more knowledge on its activity profile, cathepsin B was isolated primarily for furt4er studies 
described in Chapter 4, and acid a-glucosidase was isolated for these studies and was also used 
to raise anti-a-glucosidase antibodies in rabbits for envisioned immunocytochemical studies to 
confirm the intracellular location of the enzyme. 
3.2 Cathepsin S 
Mature active cathepsin S is a single-chain polypeptide comprising 217 amino acid residues 
(24000 kDa) . The NH2-terminal prepro extension is 114 amino acids long in the human 
(Wiederanders et al., 1992; Shi et ai., 1992) and 112 in the rat (patanceska and Devi, 1992) 
enzymes, respectively. The only potential glycosylation sites are located at position N-ll _ T9 in 
the human enzyme and at position N-13 _S-ll in the rat enzyme (Shi et al., 1994). Thus, they are 
located in the propeptide region, which indicates that maturation of procathepsin S occurs after 
delivery to the final compartment, the lysosome (Kirschke and Wiederanders, 1994). 
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The enzyme is unevenly distributed between organs. Cathepsin S protein has been detected in 
high concentrations in spleen and lung (Kirschke et aI. , 1989), and similar results have been 
described by Qian et al. (1989) for cathepsin S mRNA. Petanceska and Devi (1992) presented 
results on the expression of high levels of cathepsin S mRNA in ileum, brain, thyroid, and ovary. 
In a subsequent study Patanceska et al. (1996) revealed, through in situ hybridization analysis of 
the adult rat brain, spleen and lung, that cathepsin S mRNA is preferentially expressed in cells of 
mononuclear-phagocytic origin. 
The isoelectric points of bovine cathepsin S have been measured in the range 6.3-7.0 (Kirschke 
et aI. , 1989). The use of synthetic peptide substrates and low Mr inhibitors allows the 
characterisation of substrate-binding sites. Cathepsin S does not prefer bulky hydrophobic 
residues in the S2 and S3 binding sub sites as cathepsin L does. Instead, less bulky hydrophobic 
residues increase the specificity constant kcatlKm (Kirschke and Wiederanders, 1994). Bulky 
hydrophobic residues such as phenylalanine in the P2 position of peptidyl acylhydroxamate-type 
irreversable inhibitors (Bromme· and Demuth, 1994) reveal high k:JKi (8400 MI sec·I ) values in 
comparison to glycine, for example, in this position (780 MI sec·I ) (Bromme and Kirschke, 
1993), indicating strong hydrophobic interactions at the S2 sub site of the cathepsin S active 
centre (Kirschke and Wiederanders, 1994). 
Cathepsin S is active toward proteins and synthetic peptide substrates over the range of pH 5.0 to 
8.0 (Xin et al., 1992; Kirschke et aI. , 1989; Bromme et aI. , 1989, 1993). The stability of active 
enzyme above pH 7.0 (Bromme et aI. , 1993) is a remarkable property of cathepsin S. It is 
capable of hydrolysing protein substrates (Kirschke et aI. , 1989) as fast as cathepsin L. It shows 
collagenolytic (Kirschke et aI. , 1989) and elastinolytic (Xin et aI. , 1992) activities. Cathepsin S 
also has the ability to degrade soluble proteins as well as insoluble elastin at acid and neutral pH 
values. The action of cathepsin S on the oxidised B chain of insulin is very similar to that of 
cathepsin L with one exception: the Tyr26 -Thr27 bond is resistant to cathepsin S, even after 10 h 
incubation (Brbmme et aI. , 1989). 
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3.2.1 Cathepsin S assay 
Cathepsin S activity was assayed using the synthetic substrate Z-Phe-Arg-NHMec for routine 
assays and Bz-Phe-Val-Arg-NHMec for more specific assays. Both substrates liberate the 
intensely fluorescent 7-amino-4-methylcoumarin group upon hydrolysis (Barrett and Kirschke, 
1981; Kirschke and Wiederanders, 1994). These substrates are, however, also cleaved by other 
proteinases such as cathepsin B and L and no peptide derivative has been described so far that is 
specific for cathepsin S at acidic pH values. However, by preincubating at pH 7.5 for 1 h at 
40°C, the activities of cathepsins L, B, and H are completely abolished, whereas cathepsin S 
retains 60-70% of its activity (Kirschke et al., 1989). 
3.2.1.1 Reagents 
Buffer/activator [0.1 rnM K-phosphate, 5 rnM Na2EDTA, 0.02% em/v) NaN}, 5 rnM 
dithiothreitol. pH 7.5] . The buffer was made up to 4/3 times the final (nominal) concentration to 
accommodate dilution in the assay. KH2P04 (9.1 g), Na2EDTA (0.93 g) and NaN3 (0.13 g) were 
dissolved in 450 ml dist.H20, adjusted to pH 7.5 with KOH, and made up to 500 ml. 
Immediately before use, dithiothreitol was added to the buffer to 5 rnM (i.e. 0.51 g/500 ml). 
1 rnM Z-Phe-Arg-NHMec substrate stock solution. Z-Phe-Arg-NHMec (1 mg) was dissolved in 
DMSO (1.5 ml), divided into 50 ~l aliquots and stored at -4°C. When required, 10 ~l was 
diluted to 800 ~l with dist.H20, giving a working strength of 12.5 ~. 
10 rnMBz-Phe-Val-Arg-NHMec substrate stock solution. Bz-Phe-Val-Arg-NHMec (7.18 mg) 
was dissolved in DMSO (1 ml), divided into 50 ~l aliquots and stored at _4°C. When required, 
10 ~l was to diluted 8 ml with dist.H20 , giving a working strength of 12.5 ~. 
Stopping reagent [100 rnM Na-monochloroacetate, 30 rnM Na-acetate, 70 rnM acetic acid, 
pH 4.3]. Na-monochloroacetate (5 .83 g), Na-acetate (2.04 g), and glacial acetic acid (2.0 ml) 
were dissolved in 450 ml dist.H20, adjusted to pH 4.3 with NaOH, and made up to 500 ml 
(made as described by Kirschke and Wiederanders, 1994). 
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Diluent [0.01% Triton X-100. 100 mM K-phosphate. 1 mM N8,,2EDTA pH 7.5]. Triton X-100 
(10 J..lI), KH2P04 (1.36 g) and Na2EDTA (0.19 g) were dissolved in 95 ml dist.H20, adjusted to 
pH 7.5 with KOH and made up to 100 ml. 
1 mM 7-amino-4-methylcoumarin standard. 7-amino-4-methylcoumarin (1.8 mg) was dissolved 
in DMSO (10 ml). The standard was used as a 0.5 J..LM solution by diluting stock solution (5 J..lI) 
in assay buffer/activator (10 ml). 
3.2.1.2 Procedure 
Microassay. The enzyme sample was diluted to 100 J..lI, and 500 J..lI of buffer/activator was 
added, mixed in and preincubated for 60 min at 40°C. Thereafter, 60 J..lI of this solution was 
placed in a Flouronunc maxisorp microtitre plate well, and 25 J..lI of substrate solution was added 
and mixed in. After 10 min at 37°C the fluorescence of the free aminomethylcoumarin was 
determined in a fluorescent microplate reader (Cambridge Technology, Model 7620) with 
excitation at 370 om and emission at 460 om. The enzyine activity units were taken as equivalent 
to the arbitrary fluorescence values. 
Macroassay. The enzyme sample was diluted to 150 J..lI, and 750 J..lI of buffer/activator was 
added, mixed in and preincubated for 60 min at 40°C. Thereafter, 150 J..lI of substrate solution 
was added, mixed in and incubated for 10 min at 37°C. Stopping reagent (2 ml) was added and 
the solution vortexed. The fluorescence of the free aminomethylcoumarin was determined in a 
Hitachi F-2000 spectrofluorimeter with excitation at 370 om and emission at 460 om. 
Continuous assays in a temperature controlled cell were also carried out by eliminating the 
addition of the stopping reagent. 
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According to Barrett and Kirschke (1981), the reading given by the 0.5 J.!M standard can be 
taken to be equal to 1000 arbitrary enzyme units, which in tum is equal to 0.1 mU of enzyme 
activity. The reading given by the 0.5 J..lM standard was 18 904 and thus milliunits of activity in a 
sample could be calculated as follows : 
. .. fluorescence intensity x 0.1 mU 
mUruts actIVIty = 18904 
The above procedure was employed for the assay of cathepsin S in the presence of cathepsins L, 
B, and H. If these enzymes were absent, an assay buffer/activator of pH 6.5 and a preincubation 
time of 5 min. was used. 
3.2.2 Purification of cathepsin S 
Cathepsin S has been purified from bovine (Xin, et a!., 1992; Bromme, et ai., 1989), rabbit 
(Maciewicz and Etherington, 1988), rat, and human (Kirschke and Wiederanders, 1994, Lemere 
et a!. , 1995) tissues, and from Saccharomyces cerevisiae expressing the human enzyme 
(Bromme et a!., 1993). The amino acid sequences have been reported from the bovine 
(Wiederanders et a!., 1991 ; Ritonja et ai., 1991), rat (petanceska and Devi, 1992), and human 
(Wiederanders et a!. , 1992; Shi et a!. , 1992) enzymes. cDNAs have been cloned from bovine 
(Wiederanders et ai., 1991), rat (petanceska and Devi, 1992), and human (Wiederanders et a!. , 
1992; Shi et ai., 1992) cathepsin S. 
The purification methods used to date for the isolation of cathepsin S from a number of different 
organs and species are very similar. The methods generally include an acid autolysis step, 
ammonium sulfate fractionation, ion exchange, molecular exclusion chromatography, affinity 
chromatography and chromatofocusing (Kirschke et a!. , 1986; 1989; Dolenc, et ai. , 1992; 
Xin et a!. , 1992; Kirschke and Wiederanders, 1994). However, the above procedures are. both 
long and costly, so in the present study an attempt was made to develop a method that not only 
incorporated fewer steps but also techniques that were relatively cost effective. 
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3.2.2.1 Reagents 
Homogenisation buffer [50 mM Na-acetate, 150 mM NaCl, 1 mM Na2EDTA. pH 4.5]. Glacial 
acetic acid (2.86 ml), NaCI (8 .77 g) and Na2EDTA (0.37 g) were dissolved in 950 ml dist.H20 , 
adjusted to pH 4.5 with diluted NaOH, and made up to I litre. 
Buffer A [20 mMNa-acetate, 1 mMNa2EDTA. 0.02% (m/v) NaN}, pH 5.0]. Glacial acetic acid 
(2.29 ml), Na2EDTA (0.74 g) and NaN3 (0.4 g) were dissolved in 1.9 litres of dist.H20 , adjusted 
to pH 5.0 with diluted NaOH, and made up to 2litres. 
Buffer B [100 mM Na-acetate, 500 mM NaCI, 1 mM Na2EDTA. 0.02% NaN] pH 5.5]. Glacial 
acetic acid (11.44 ml), NaCI (58.44 g), Na2EDTA (0.74 g) and NaN3 (0.4 g) were dissolved in 
1.9litres of dist.H20, adjusted to pH 5.5 with dilute NaOH, and made up to 2litres. 
Buffer C [20 mM K-phosphate 1 mM Na2EDTA. 0.02% NaN}, pH 6.5]. KH2P04 (2.72 g), 
Na2EDTA (0.37 g) and NaN3 (0.2 g) were dissolved in 950 ml of dist.H20, adjusted to pH 6.5 
with diluted NaOH, and made up to 1 litre. 
S-Sepharose fast flow. S-Sepharose was prepared by diluting 90 ml of the supplied hydrated gel 
in 180 ml of buffer A, and packing the resulting slurry into a glass column under gravity. The 
column bed was initially regenerated with two column volumes of 2 M NaCI in buffer A and 
equilibrated with five column volumes of buffer A, before use. In between purification 
procedures, the column was regenerated with one column volume of 2 M NaCI in buffer A. On 
occasions, one column volume of 1 M NaOH was used to remove precipitated proteins and 
lipids. In either case the column was re-equilibrated with five column volumes of buffer A, 
before use. 
Sephacryl S-100 HR. Sephacryl S-100 was prepared by diluting 500 ml of the supplied hydrated 
gel in 1000 rnl of buffer B, and packing the resulting slurry into a glass column under gravity. 
The column was initially equilibrated with five column volumes of buffer B, before use. In 
between purification procedures, the column was re-equilibrated with two column volumes of 
buffer B. 
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Hydroxyapatite. Hydroxyapatite was prepared by diluting 10 ml of the supplied hydrated gel in 
20 ml of buffer C, · and packing the resulting slurry into a glass column under gravity. The 
column was initially regenerated with two column volumes of 1 M KH2P04 in buffer C. The gel 
was equilibrated with five column volumes of buffer C, before use. In-between purification 
procedures, the column was regenerated with two column volumes of 1 M KH2P04 in buffer C, 
and re-equilibrated with buffer C. 
Bovine spleen. Fresh bovine spleen was obtained from Cato Ridge Abattoir. After removing the 
capsule, the spleen was diced into 2 x 2 cm cubes and frozen at -70°C for at least 3 days before 
use. 
3.2.2.2 Procedure 
The spleen was prepared essentially according to Kirschke et al. (1989). Frozen, diced spleen 
was allowed to thaw overnight at 4°C and homogenised at a ratio of 1: 1 (spleen mass to buffer) 
in a Waring blendor with buffer A for 3 min. The homogenate was centrifuged (9000 x g, 
20 min, 4°C), the supernatant decanted and adjusted, with stirring, to pH 4.2 with diluted glacial 
acetic acid and centrifuged as before. 
Three-phase partitioning was effected on the pH 4.2 acid supernatant using a 15 to 30% 
ammonium sulfate cut as described in Section 2.6. The sample was loaded directly onto a 
column (2.5 x 18.5 cm = 90.8 ml) of S-Sepharose, equilibrated with buffer A, and eluted with a 
0-300 mM NaCI gradient in buffer A, all at 50 mlIh. Fractions corresponding to the active peak 
were pooled and concentrated by dialysis against sucrose to approximately 1-5% of the volume 
of the molecular exclusion column used in the next step. 
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The concentrated sample from ion exchange chromatography was applied to a calibrated column 
of Sephacryl S-100 (2.5 x 84 cm = 412 rnI), equilibrated with buffer B and run at 25 mlIh. 
Active fractions in the Mr range 18 000-25 000 were pooled and concentrated against sucrose. 
The sample from gel filtration was loaded onto a column of hydroxyapatite (Section 2.7) 
(1.0 x 5 cm = 3.9 rnI), equilibrated in buffer C, and eluted with a 400 mM KH2P04 in buffer C, all 
at 18 mlIh . The active peak eluted at approximately 180 mM K-phosphate and was concentrated 
using an Ultrafuge ultrafiltration centrifuge filter. 
3.2.2.3 Results 
The purification of cathepsin S is summarized in Table 3. 
Table 3. The purification of cathepsin S from bovine spleen 
Total Total Specific Purifi-
Volume protein activity activity cation Yield 
(rnl) (mg) (units) (units/m~) (fold) (%) 
Homogenate 490 10 173 7342 0.72 (1) (100) 
TPP (15-30%) 31 134 6874 52.1 72.4 93 .6 
S-Sepharose 8.5 29.2 1821 62.4 86.6 24.8 
Sephacryl S-100 9.8 0.168 260.8 1552 2156 3.6 
Hydroxyapatite l.0 0.106 224.4 2117 2940 3.0 
Freezing of tissue prior to homogenization is essential to disrupt lysosomes and facilitate the 
release oflysosomal enzymes. Using TPP early on in the purification, it was possible to obtain a 
fraction from the acid supernatant selectively enriched in cathepsin S. Contaminant enzymes such 
as cathepsins Hand L were removed in the ion exchange step (Fig. 2), as they eluted after 
cathepsin S. However, cathepsin B eluted in the same fraction and was removed in the 
subsequent Sephacryl S-100 (Fig. 3) step which gave good resolution of these two enzymes. The 
cathepsin S was subsequently fractionated on hydroxyapatite (Fig 4), which eluted a small 
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Figure 2. Chromatography of the 15-30% pH 4.2 TPP fraction on S-Sepharose. 
Column, 2.5 x 18.5 cm (91 ml bed volume), equilibrated in 20 mM Na-acetate, pH 5.0, containing 
1 mM Na2EDT A, 0.02% NaN3 and eluted with a 0-300 mM NaCI gradient in the same buffer applied 
at -i.; flow rate, 50 ml/h (10 cm/h); fractions, 8.3 ml (10 min). (-) A280, ( ••• ) cathepsin S activity (units) 
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Figure 3. Chromatography of the pH 5.0 S-Sepharose fraction of cathepsin S on Sephacryl S-100. 
Column 2.5 x 84 cm (412 ml bed volume); buffer, 100 mM Na-acetate, pH 5.5, containing 500 mM 
NaCl, 1 mM Na2EDTA, 0.02% NaN3; flow rate, 25 mlIh (5 cm/h); fractions, 5 ml (12 min). (-) A1EO, 
( ... ) cathepsin S activity (units) against Z-Phe-Arg-NHMec, (H) pooled fraction. 
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Figure 4. Affinity chromatography of the pH 5.5 Sephacryl S-lOO fraction on hydroxyapatite. 
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Column, l.0 x 5.0 cm (3.9 m1 bed volume), equilibrated in 20 mM KH2P04, pH 6.5, containing 1 mM 
Na2EDTA, 0.02% NaN3 and eluted with 400 mM K-phosphate, pH 6.5, containing 1 mM Na2EDTA, 
0.02% NaN3 applied at J..; flow rate, 18 mlIh (4.6 cm/h); fractions, 1 m1 (3 .3 min). (-) Azso; 
( .. . ) cathepsin S activity (units) against Z-Phe-Arg-NHMec, (H) pooled fraction. 
On non-reducing Tris-tricine SDS-PAGE (Fig. 5) the progression of the isolation can be seen. 
Lane b of Fig. 4 shows the proteins in the homogenate supernatant, lanes c and d show the 
supernatant after acid precipitation and TPP, and lanes e and f show the TPP fraction after ion 
exchange and molecular exclusion chromatography. Note the purification after molecular 
exclusion chromatography, with the removal of all higher molecular weight proteins. Lane g 
shows a single protein band corresponding to 14 kDa. Cathepsin S samples have never been 
analysed on Tris-tricine SDS-P AGE, therefore this anomalous behaviour has not been previously 
noted. 
a b c d e f g 







Figure 5. Non-reducing Tris-Tricine SDS-PAGE of cathepsin S isolated from bovine spleen. 
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Samples were boiled in non-reducing treannent buffer and loaded onto a 10% Tris-Tricine gel. 
(b) Spleen homogenate fraction; (c) pH 4.2 acid precipitate supernatant; (d) TPP fraction; 
(e) S-Sepharose fraction; (0 Sephacryl S-loo fraction; (g) hydroxyapatite fraction; (a, h) MW markers 
(phosphorylase b, Mr 97 000; BSA, Mr 68 000; ovalbumin, Mr 45 000; carbonic anhydrase, Mr 30 000; 
trypsin inhibitor, Mr 20100; lysozyme, Mr 14000). Visualised using silver staining. 
3.2.3 pH Optimum of cathepsin S using constant ionic strength AMT buffers 
In a single component buffer of constarit molarity, the ionic strength changes with the pH. Since 
cysteine cathepsins are sensitive to ionic strength, this can give an erroneous impression of the 
pH optimum (Dehrmann et al., 1995; 1996). To determine the pH optimum of cathepsin S, 
therefore, the activity was assayed against Bz-Phe-Val-Arg-NHMec in a constant ionic strength 
AMT buffer (Ellis and Morrison, 1982), to remove the possible influence of ionic strength on the 
activity of the enzyme. The assay used was based on that described by Dehrmann et al. (1995) . 
3.2.3.1 Reagents 
Acetate-MES-Tris (AMT) buffers (50 mM acetate. 50 mM MES and 100 mM Tris. 5 mM 
Na2EDTA). The buffers were made up to 4/3 times the fmal (nominal) concentration to 
accommodate dilution in the assay. Glacial acetic acid (0.953 ml), MES (3.26 g), Tris (4.04 g) 
and Na2EDTA (0.62 g) were dissolved in 200 m1 of dist.H20. The solution was divided into 
10 aliquots (20 ml), each of which was titrated to a pH value in the range 4.0-8.5 using Hel or 
NaOH, and diluted to 25 ml. 
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10 mM Bz-Phe-Val-Arg-NHMec substrate stock solution. Bz-Phe-Val-Arg-NHMec (7.18 mg) 
was dissolved in DMSO (1 mI), divided into 50 ~l aliquots and stored at -4°e. When required, 
27 ~l was diluted to 8 mI with dist.H20, giving a working strength of34 ~. 
Diluent [0.01% (v/v) Triton X-lOO, 100 mM K-phosphate, 1 mM Na2EDTA pH 7.5]. Triton 
X-100 (10 ~l), KH2P04 ( l.36 g) and Na2EDTA (0.19 g) was dissolved in 95 mI dist.H20 , 
adjusted to pH 7.5 with KOH and made up to 100 mI. 
1 M dithiothreitol (OTT). DTT (154.2 mg) was dissolved in 1 mI dist.H20 
3.2.3.2 Procedure 
AMT buffers of constant ionic strength were prepared according to Ellis and Morrison (1982) 
with an ionic strength of 0.1 and at pH 4.0, 4.5, 5.0, 5.5, 6.0, 6.5, 7.0, 7.5, 8.0, and 8.5. All 
solutions were equilibrated to 37°e, except the diluted enzyme solution which was kept on ice. 
Each assay consisted of 750 ~l buffer, 4 ~l DTT, and 96 ~l of appropriately diluted enzyme. 
This was allowed to activate for 2 min at 37°e, followed by the addition of 150 ~l of substrate 
solution. The change in fluorescence was measured continuously at 37°e in a temperature-
controlled Hitachi F-2000 recording spectrofluorometer, with excitation at 370 om and emission 
at 460 om. Data was sampled at lOs intervals over a 10 min period and activity was determined 




The profiles shown in Fig. 6 illustrate the activity of cathepsin S over a wide pH range, firstly, in 
the presence of constant ionic strength AMT buffers, and secondly, the profile reported by 
Kirschke et al. (1989) who used a range of buffers of varying ionic strength. The graph indicates 
an optimum of pH 6.5 with constant ionic strength AMT buffers which is similar to the 
previously reported results of Kirschke et al. (1989). However, cathepsin S shows remarkable 
stability in the presence of constant ionic strength AMT buffers as it remains over 55% active 
over the entire pH range, whereas the results of Kirschke et al. (1989) show a large drop in 
activity either side of the pH optimum. 
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Figure 6. pH-Activity profiles of bovine spleen cathepsin S. 
Cathepsin S isolated in this study (e), was assayed with Bz-Phe-Val-Arg-NHMec in buffers of constant 
ionic strength as described in Section 3.2.3. Cathepsin S pH-activity profile of Kirschke et al. 
(1989) (0), was assayed against Z-Phe-Arg-NHMec in Na-acetate (PH 4.5-5.5), Na-phosphate (PH 6.0-
7.5), and TrisIHCI pH (7.5-8.5) buffers. 
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3.2.4 Active site titration of cathepsin S with E-64 
3.2.4.1 Reagents 
Buffer/activator [0.1 mM K-phosphate, 5 mM Na2EDTA 0.02% NaNa, 5 mM dithiothreitol, 
pH 6.5]. The buffer was made up to 4/3 times the final (nominal) concentration to accommodate 
dilution in the assay. KH2P04 (9.1 g), Na2EDTA (.93 g) and NaN3 (0.13 g) were dissolved in 
450 mI dist.H20, adjusted to pH 6.5 with KOH, and made up to 500 mI. Immediately before use, 
dithiothreitol was added to the buffer to 5 mM (i.e. 0.51 g/500 mI). 
10 mM Bz-Phe-V al-Arg-NHMec substrate stock solution. As in Section 3.2.1. 
Diluent [0.01% Triton X-lOO, 100 mM K-phosphate, 1 mM Na2EDTA pH 6.5]. Triton X-100 
(10 Ill), KH2P04 (1.36 g) and Na2EDTA (0.19 g) were dissolved in 95 mI dist.H20, adjusted to 
pH 6.5 with KOH and made up to 100 mI. 
10 mM E-64 stock solution. E-64 (1.8 mg) was dissolved in DMSO (500 Ill) . 
3.2.4.2 Procedure 
Active site titration of cathepsin S with the inhibitor E-64 was done essentially as described by 
Barrett and Kirschke (1981). Enzyme (8 Ill), of an appropriate dilution, was added and 
incubated together with the inhibitor (5 III of a 1-10 11M solution) for 30 min at 37°C in the 
presence of the pH 6.5 assay buffer/activator (39 Ill) . After 30 min, the mixture was diluted to 
200 III by the addition of Triton X-lOO diluent. Aliquots (150 Ill) were assayed against Bz-Phe-
Val-Arg-NHMec using the continuous assay at pH 6.5 as described in Section 3.2.1 
(macroassay). From this a graph of fluorescence versus the concentration of E-64 was plotted 
and the concentration of E-64 which halted the enzyme reaction (i.e. where the graph intercepts 
the x-axis) is designated [Eo] . 
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3.2.4.3 Results 
In order to calculate the percentage of active enzyme present in the isolated sample {to calculate 
[Eo] and hence kat (Section 3.2.5)}, active site titration of cathepsin S by E-64 was carried out. 
This revealed that 42% of the purified sample was active enzyme. [Eo], the absolute 
concentration of active enzyme, was calculated to be 1.85 ~. 
3.2.5 Determination of Kim V I1I3J: and kart values 
3.2.5.1 Reagents 
Buffer/activator [0.1 roM K-phosphate, 5 roM Na2EDTA, 0.02% NaN}, 5 roM dithiothreitol, 
pH 6.5] : As described in Section 3.2.4. 
10 mM Bz-Phe-Val-Arg-NHMec substrate stock solution. As described in Section 3.2.1. 
Diluent [0.01% Triton X-lOO, 100 mM K-phosphate, 1 mM Na2EDTA, pH 6.5]. As described 
in Section 3.2.4. 
3.2.5.2 Procedure 
To detennine Krn and V max, a semicontinuous assay in a fluorescent microplate reader (Cambridge 
Technology, Model 7620) at 37°C was used as described by Dehnnann et al. (1995). For each 
determination, buffer/activator (75 ~l) plus appropriately diluted enzyme (12.5 ~l) was added to 
each of 14 wells of a white Fluoronunc maxisorp microtitre plate and incubated for 2 min. Serial 
two-fold dilutions of Bz-Phe-Val-Arg-NHMec were added to duplicate wells in a row of seven, 
giving final substrate concentrations ranging from 50 to 0 .78125~. After 2, 4, and 6 min, the 
wells were read, with excitation at 370 nm and emission at 460 nm. Readings at three different 
times provides a check on the linearity of the progress curve. Dehnnann et al. (1995) established 
that before 2 min the reaction rate increases with time, but the reaction was linear between 2 and 
6 min. Krn and V max values were determined using the direct linear plot of Eisenthal and Cornish-
Bowden (1974), implemented using the programme HYPER obtained from Dr. lS. Easterby 
(University of Liverpool). [Eo] values were established as described in Section 3.2.5, and the 
relationship 
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was used to calculate kat from V max values. 
3.2.5.3 Results 
Th~ measurement of Km and V max for bovine spleen cathepsin S against the synthetic substrate 
Bz-Phe-Val-Arg-NHMec at pH 6.5 was carried out as described in Section 3.2.5. From the 
Km (3.91~, Vmax (5.39 !JM.S·I), and [Eo] (1.85 !JM, Section 3.2.4), kat (2.9 S·l) was 
calculated, using the equation in Section 3.2.5.2. 
3.3 Cathepsin B 
Cathepsin B [BC 3.4.22.1] is an abundant lysosomal cysteine proteinase which plays a role in a 
variety of physiological processes, such as general intracellular protein turnover (Barrett and 
Kirschke, 1981), bone resorption (Delaisse et aI., 1991), cartilage proteoglycan breakdown 
(Buttle and Saklatvala, 1992) and antigen processing (Guagliardi et aI. , 1990). However, it has 
also been implicated in pathological states such as arthritis (Mort et aI., 1984), muscular 
dystrophy (Gopalan et aI., 1987; Katunuma and Kominami, 1987) and tumour metastasis (Sloane 
et ai., 1990). 
Human cathepsin B was the first lysosomal cysteine proteinase whose crystal structure was 
elucidated (at a 2.15 A level) by X-ray crystallography (Musil et aI., 1991). The enzyme shows a 
two-domain structure, the L domain containing residues 13-147 and 251-254 and the R domain 
containing residues 1-12 and 148-250. Complete amino acid sequences of cathepsin B have been 
determined for rat (Takio et aI. , 1983), human (Ritonja et aI., 1985), and bovine (Meloun et aI. , 
1988) cathepsin B. From cDNA clones encoding for mouse and human (Chan et ai., 1986) 
cathepsin B, it has been demonstrated that this enzyme is synthesised as a large-Mr precursor 
containing signal and pro-sequences. The precursor undergoes multiple processing steps, the 
most important of which results in the removal of the 62 residue pro-region to yield the active, 
single-chain form of the enzyme (Chan et aI. , 1986). 
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Mature cathepsin B appears to be unique with respect to other members of the cysteine 
proteinase family in that it possesses both endopeptidase and exopeptidase (carboxydipeptidase) 
activities (Aronson and Barrett, 1979; Barrett and Kirschke, 1981). The optimal activity of 
cathepsin B against most substrates was originally thought to occur in slightly acidic media 
(Barrett and Kirschke, 1981), while at pH values above 7.0 its activity was shown to fall sharply 
and was thought to be due to irreversible inactivation (Barrett, 1973). The action of cathepsin B 
on biological peptides . at acidic pH was shown to occur predominantly through its 
carboxydipeptidase activity (Takahashi et al., 1986). The active-site model which was drawn 
based on these observations (Takahashi et al., 1986) has largely been confinned with data on the 
crystal structure of cathepsin B (Musil et aI. , 1991). Due to the occluding loop which partly 
covers the active-site cleft of human cathepsin B, and the presence within this loop of two pH-
sensitive histidine residues, the active-site of cathepsin B can easily accommodate C-terminal 
carboxyl groups of pep tides and proteins (Musil et al., 1991). 
Cathepsin B is also capable of endoproteolytic attack (Barrett and Kirschke, 1981), and it 
appears that this catalytic mechanism may predominate at physiological pH if the enzyme is 
properly stabilised. Proof for this might be the observed speed at which the enzyme autolyses 
in vitro at pH 7.2 if no exogenous protein substrate is present, e.g. extracellular matrix 
components like fibronectin (Buck et aI. , 1992). Indeed, inactivation of cathepsin B at pH > 7.0 
does not seem to be due to the irreversible unfolding of the enzyme as might appear from in vitro 
studies using synthetic substrates (Barrett and Kirschke, 1981). The fact that at pH > 7 human 
cathepsin B undergoes a time-dependent autodegradation, which can be slowed by the presence 
of substrates such as fibronectin or even blocked by the addition of E-64 (Buck et aI. , 1992), 
argues against the contention that at pH > 7.0 cathepsin B is irreversibly denatured. Some earlier 
work (Willenbrock and Brocklehurst, 1985) showing that the specificity constant (kcatlKrn) of 
cathepsin B for a dibasic naphthylamide substrate was about 4 fold higher at pH 8.0 than at 
pH 6.0 is also in good agreement with this more recent finding (Buck et aI. , 1992). Depending 
on the substrates used, at least seven separate ionisation groups were shown to be involved iri 
substrate binding and hydrolysis by cathepsin B (Hasnain et al., 1992). Altogether these results 
demonstrate that the pH-dependent catalytic activity of cathepsin B is extremely complex and 
depends not only on the composition of the medium and the nature and conformation of the 
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substrate, but also on the presence or absence of stabilising factors (Keppler and Sloane, 1996). 
Dehnnann et al. (1995; 1996) showed that the activity of cathepsin B and that of cathepsin L is 
affected by specific buffer ions as well as pH, ionic strength and the presence of protein 
substrates. The stability is also affected by the activation state of the enzyme, which may in part 
explain the markedly different results which have been previously reported. Dehnnann et al. 
(1996) found the pH optimum of cathepsin B to be pH 7-7.5. 
3.3.1 Cathepsin B assay 
Cathepsin B was originally assayed with Bz-DL-Arg-NPhN02 or Bz-Arg-2-NNap as substrates 
(Barrett, 1972; 1976). However, it was found that these substrates were not only insensitive, but 
also susceptible to cathepsin H, so the results obtained were not specific (Barrett and Kirschke, 
1981). As has been found with the serine proteinases, substrates containing longer peptide 
sequences are much more selective and specific than the blocked amino acid derivatives. Thus 
naphthylamide substrates containing the -Arg-Arg- sequence, introduced by McDonald and Ellis 
(1975), were found to be extremely sensitive to cathepsin B, and resistant to cathepsin Hand L 
(Kirschke et aI. , 1980). The most sensitive, safe, and convenient leaving group for substrates of 
the cysteine proteinases is 7-amino-4-methylcoumarin, and just as Z-Arg-Arg-NNap is specific 
for cathepsin B, so is Z-Arg-Arg-NHMec which has proven to be an almost ideal substrate for 
cathepsin B (Barrett and Kirschke, 1981). 
3.3.1.1 Reagents 
Buffer/activator [0.1 M Na-phosphate. 4 mM Na2EDTA 0.02% NaNJ, 5 mM dithiothreitol, 
pH 6.0]. NaH2P04 (6.90 g), Na2EDTA (0.93 g) and NaN3 (0.1 g) were dissolved in 450 rnl 
dist.H20 , adjusted to pH 6.0 with NaOH and made up to 500 rnl. Immediately before use, 
dithiothreitol was added to 5 mM (i.e. 0.51 g/500 rnl) . 
1 mM Z-Arg-Arg-NHMec substrate stock solution. Z-Arg-Arg-NHMec (1 .1 mg) was dissolved 
in DMSO (1.5 rnl), divided into 100 III aliquots and stored at -4°C. When required, 100 III was 
diluted to 2.5 rnl with dist.H20 , giving a working strength of 40 !J.M. 
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Diluent [0.1% Brijl Brij (0.1 g) was dissolved in 95 ml dist.H20, and made up to 100 ml. 
1 mM 7-amino-4-methylcoumarin standard. 7-amino-4-methylcoumarin (1.8 mg) was dissolved 
in DMSO (10 ml). The standard was used as a 0.5 ~ solution by diluting stock solution (5 Ill) 
in assay buffer/activator (10 ml). 
3.3.1.2 Procedure 
Microassay. The enzyme sample, diluted to lOlli, and 75 III of buffer/activator was added to 
wells of a white Fluoronunc maxisorp microtitre plate and preincubated for 2 min at 37°C. 
Thereafter, 25 III of substrate solution was added and mixed in. After exactly 10 min at 37°C the 
fluorescence of the free amino methyl coumarin was determined in a fluorescent microplate reader 
(Cambridge Technology, Model 7620) with excitation at 370 nm and emission at 460 nm. The 
enzyme activity units were taken as equivalent to arbitrary fluorescence values. 
Macroassay. The enzyme sample, diluted to 125 Ill, and 750 III of buffer/activator was added 
and preincubated for 2 min at 37°C. Thereafter, 125 III of substrate solution was added and 
mixed in. The fluorescence of the free amino methyl coumarin was determined continuously for 
10 min in a Hitachi F-2000 spectroflourimeter with excitation at 370 nm and emission at 460 nm. 
This was used to give units of activity for a 10 min assay and to assess linearity of the reaction. 
According to Barrett and Kirschke (1981), the reading given by the 0.5 llM standard can be 
taken to be equal to 1000 arbitrary enzyme units, which in tum is equal to 0.1 mD of enzyme 
activity. The reading given by the 0.5 j.!M standard was 19 652 and thus rnilliunits of activity in a 
sample could be calculated as follows: 
D 't " - fluorescence intensity x 0.1 mD m ru s actIVIty - 19 652 
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3.3.2 Purification of cathepsin B 
The isolation of cathepsin B has mostly relied on specific techniques such as covalent 
chromatography using an amino phenylmercuric acetate coupled to Sepharose (Barrett and 
Kirschke, 1981), or the method of Rich et al. (1986) which uses a specialised affinity resin, 
Agarose-Ahx-Gly-Phe-Gly-Sc, which is currently not commercially available. Consequently, in 
the present study it was decided to explore the possibility of developing an alternative quick, cost 
effective method for the isolation of cathepsin B from bovine spleen. 
3.3.2.1 Reagents 
Homogenisation buffer [50 mM Na-acetate. 150 mM NaCl. 1 mM NcuEDTA. pH 4.5]. 
As described in Section 3.2.2.l. 
Buffer A [20 mM Na-acetate. 1 mM Na2EDTA. 0.02% NaN3. pH 5.0]. As described in 
Section 3.2.2.l. 
Buffer B [100 mM Na-acetate. 500 mM NaCL 1 mM Na2EDTA. 0.02% NaN} pH 5.5]. 
As described in Section 3.2.2.l. 
3.3.2.2 Procedure 
Cathepsin B was isolated by a slight modification of the method used for cathepsin S, as 
described in Section 3.2.2. The TPP cut used was 30 to 40% and the cathepsin B active peak 
from Sephacryl S-100 molecular exclusion chromatography eluted between 25 to 30 kDa. 
3.3.2.3 Results 
The isolation of cathepsin B from bovine spleen is summarized in Table 4. 
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Table 4. The purification of cathepsin B from bovine spleen 
Total Total Specific Purifi-
Volume protein activity activity cation Yield 
(ml) (mg) (units) (units/mg) (fold) (%) 
Homogenate 490 10173 77221 7.59 (1) (100) 
TPP (30-40%) 31 23 .7 754.3 3l.8 4.2 0.98 
S-Sepharose 4.8 0.79 668.2 845.8 III 0.87 
Sephacryl S-100 l.0 0.007 35.7 5 100 672 0.05 
The procedure followed the same steps as the purification of cathepsin S (Section 3.2.2). 
However, a different TPP cut was used (30-40%), which selectively precipitated the cathepsin B 
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Figure 7. Chromatography of the pH 4.2 TPP fraction of cathepsin B on S-Sepharose. 
Column, 2.5 x 18.5 cm (91 ml bed volume), equilibrated in 20 mM Na-acetate, pH 5.0, containing 
1 mM Na2EDTA, 0.02% NaN3 and eluted with a 0-300 mM NaCl gradient in the same buffer applied 
at -l-; flow rate, 50 mlIh (10 cmlh); fractions, 8.3 ml (10 min). (-) A280, ( .. . ) cathepsin B activity (units) 
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Figure 8. Chromatography of the pH 5.0 S-Sepharose fraction of cathepsin Bon Sephacryl S-100. 
Column. 2.5 x 84 cm (412 ml bed volume); buffer, 100 mM Na-acetate, pH 5.5, containing 500 mM 
NaCI, 1 mM Na2EDTA, 0.02% NaN3; flow rate, 25 m1/h (5 cmlh); and fractions, 5 ml (12 min). 
(-) A280; ( ••• ) cathepsin B activity (units) against Z-Arg-Arg-NHMec, (H) pooled fraction. 
The progression of the isolation was analysed by non-reducing Tris-tricine SDS-PAGE (Fig. 9). 
Lane f shows a single protein band of 28 kDa which corresponds to previously reported results 
for the MW of cathepsin B (Barrett, 1973; Barrett and Kirschke, 1981). 
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Figure 9. Tris-Tricine SDS-PAGE (Section 2.4.2) of cathepsin B fractions isolated from bovine spleen. 
Samples were boiled in non-reducing treatment buffer and loaded onto a 10% Tris-Tricine gel. 
(b) Spleen homogenate fraction; (c) pH 4.2 acid precipitate supernatant; (d) TPP fraction; 
(e) S-Sepharose fraction; (t) Sephacryl S-l00 fraction; and (a, g) MW markers (phosphorylase b, Mr 
97000; BSA, Mr 68 000; ovalbumin, Mr 45000; carbonic anhydrase, Mr 30 000; trypsin inhibitor, Mr 
20100; lysozyme, Mr 140(0). Visualised using silver staining. 
3.4 Acid a-glucosidase 
Acid a-glucosidase catalyses the hydrolysis of both a-l,4 and a-l,6 glycosidic linkages from the 
non-reducing tenninus of various substrates (Hoefsloot et ai., 1988; Onodera et ai., 1989). 
Mammalian a-glucosidase acts not only on substrates of low molecular weight, such as maltose, 
but also on high molecular weight substrates, such as glycogen (Matsui et ai., 1984). In general, 
mammalian a-glucosidases are classified into two groups, acid a-glucosidase (optimum pH 4-5), 
and neutral a-glucosidase (optimum pH 6-7) according to their pH optima. The essential 
function of acid a-glucosidase in lysosomes is the degradation of glycogen to glucose which is 
transported out of the lysosomes and reutilized' in the cytoplasm (Mancini et aI., 1990; Jonas 
et aI., 1990). The importance of acid a-glucosidase in the lysosomal degradation of glycogen is 
emphasized by the pathological conditions which ensue when the enzyme is deficient. Acid 
a-glucosidase deficiency was discovered in 1963 (Hers, 1963) as the primary defect in 
glycogenosis type II (Pompe's disease), until then known only as an inherited, generalised, 
glycogen storage disease with a fatal outcome in the first two years of life (Hers, 1963; Hers and 
De Barsy 1973). 
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For the active site of acid a-glucosidase, two conflicting proposals have been made. Jeffrey et al. 
(1970a, b) have suggested that acid a-glucosidase from rat liver lysosomes may have at least two 
catalytically active binding sites, one which can bind low molecular weight substrates such as 
maltose, and the other which can bind a-glucans such as glycogen. Palmer (1971a,b) suggested 
similar "multiple substrate binding sites" for rabbit muscle acid a-glucosidase. On the other 
hand, there are many reports that acid a-glucosidases catalyse the hydrolysis of both maltose and 
a-glucan at a single active site (Matsui and Chiba, 1983a,b; Matsui et aI. , 1984). Further 
evidence based on results of kinetic approaches and the effects of pH and temperature on the 
hydrolysis of maltose and shell fish glycogen (Onodera et aI. , 1989), and active site-directed 
inhibition and site-directed mutagenesis (Hermans et aI. , 1991) pointed to a single catalytic site 
with Asp-518 as the catalytic base and a second aspartic or glutamic acid residue acting as the 
proton donor. 
3.4.1 Acid a-glucosidase assay 
Acid a-glucosidase' activity was assayed using the synthetic substrate 4-methylumbelliferyl-
a-glucoside. This substrate liberates the fluorescent 4-methylumbelliferone group upon 
hydrolysis. The amount of substrate cleaved is equivalent to the amount of the highly fluorescent 
4-methylumbelliferone anion generated. Quenching the reaction with alkaline (PH 10.5) 
glycine:ammonium hydroxide soiution accomplishes two things; first it prevents further enzyme-
catalysed hydrolysis of the substrate and second, it converts 4-methylumbelliferone to its more 
fluorescent anion form (Daniels and Glew, 1984). 
3.4.1.1 Reagents 
Assay buffer [0.1 M Na-acetate. pH 4.5]. Glacial acetic acid (2.86 ml) was added to 450 ml 
dist.H20 , adjusted to pH 4.5 with NaOH and made up to 500 ml. 
20 mM 4-methylumbelliferyl-a-glucoside stock solution. 4-methylumbelliferyl-a-glucoside 
(0.067 g) was dissolved in 10 ml of dist.H20 , divided into 50~ ~l aliquots and stored at -40C. 
When required, it was diluted to a working strength of 0.2 mM with dist.H20 (0.1 ml to 10 ml). 
/ 
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Stopping reagent [50 mM glycine/NaOH, pH 10.5]. Glycine (3.75 g) was dissolved in 450 ml 
dist.H20, adjusted to pH 10.5 with NaOH and made up to 500 ml. 
10 rnM 4-methylumbelliferone standard. 4-methylumbelliferone sodium salt (198.2 mg) 
was dissolved in 10 ml DMSO. A standard curve was constructed by diluting the 
4-methylumbelliferone standard solution 1:1000 with water, pipetting 5 to 100 III (0.05 to 
1 nmol) into assay tubes, and adding 2.9 ml stopping reagent. The fluorescence was measured in 
a Hitachi F-200 spectrofluorimeter, with excitation at 365 nm and emission at 450 nm and 
plottted as a function of 4-methylumbelliferone concentration. 
3.4.1.2 Procedure 
The enzyme sample (10 Ill) was added to 30 III of assay buffer followed by 10 III of substrate 
solution, mixed thoroughly and incubated for 10 min at 37°C. Stopping reagent (2.95 ml) was 
added and the solution vortexed. The fluorescence of the free 4-methylumbelliferone was 
determined in a Hitachi F-2000 spectrofluorimeter, with excitation at 365 nm and emission at 
450 nm. 
3.4.2 Purification of acid a-glucosidase 
Several of the mammalian acid a-glucosidases have been purified, including those from rat liver 
(Auricchio and Bruni, 1967; Auricchio et ai. , 1968; Jeffrey et al., 1970a,b), dog liver (Torres and 
Olivarria, 1964), bovine liver (Bruni et ai. , 1970), human liver (Koster et ai., 1976; Murray et al., 
1978), porcine liver (Matsui and Chiba, 1983a), human kidney (Auricchio and Bruni, 1967; 
Auricchio et ai. , 1968), human placenta (Martiniuk et al., 1984) and rabbit muscle (palmer, 
1971a,b; Matsui et ai., 1984). The properties of many of these enzymes have been described, 
including their pH dependence, activity towards various substrates and inhibition by various 
agents (Calder and Geddes, 1989a). 
Acid a-glucosidase can be purified on the basis of its affinity to dextran gel filtration media such 
as Sephadex (Auricchio et al., 1968; Bruni et ai. , 1970), which may act as an analogue of the 
natural substrates, such as glycogen. Employing this principle, Hasilik and Neufeld (1980 a,b) 
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purified this enzyme from human placenta. They found that the enzyme contained two 
components, with molecular masses of 76 kDa and 70 kDa. Tashiro et al. (1986) also reported 
that acid a-glucosidase purified from pig liver, using Sephadex G-IOO as an affinity medium, 
contained two components. In the present study t~e procedure for the isolation of acid 
a-glucosidase was based on that of Tashiro et al. (1986) . 
3.4.2.1 Reagents 
Homogenisation "buffer" [1% NaCl, 0.1% NIl2EDTA 2% n-butanol]. NaCI (10 g) and 
Na2EDTA (1 g) were dissolved in 950 ml of dist.H20. Just before use, 20 ml of n-butanol was 
added and the volume made up to 1 litre. 
Equilibration buffer [20 mM Na-acetate, 0.02% NaN}, pH 5.8]. Glacial acetic acid (2.29 ml) 
and NaN3 (0.4 g) were added to 1.9 litres of dist.H20 , adjusted to pH 5.8 with NaOH and made 
up to 2 litres. 
Sephadex G-I00. Sephadex G-I00 was prepared by adding 30 g of the supplied xerogel to 
500 ml of dist.H20. This was boiled in a water bath for 1 h and allowed to cool to room 
temperature over 24 h. The resulting slurry was packed into a glass column under gravity. The 
column bed was equilibrated with five column volumes of equilibration buffer before use. In 
between purification procedures, the column was regenerated with one column volume of 0.25% 
maltose in equlibration buffer. 
Bovine liver. Fresh bovine livers were obtained from Cato Ridge Abattoir, cut into small pieces 
(2 x 2 cm cubes) and frozen at -70°C for at least 3 days before use. 
3.4.2.2 Procedure 
The liver was prepared essentially according to Tashiro et al. (1986). The diced liver was 
allowed to thaw overnight at 4°C and homogenised in a Waring blendor with homogenisation 
buffer. A ratio of 1:2 (liver mass to buffer) was used and the liver was homogenised for 3 min in 
100 g batches. The homogenate was centrifuged (6000 x g, 30 min, 4°C), the supernatant 
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decanted and adjusted, with stirring, to pH 4.2 with diluted glacial acetic acid and centrifuged as 
before. Three-phase partitioning was effected on the pH 4.2 acid supernatant using a 15 to 25% 
ammonium sulfate cut as described in Section 2.6. The resulting pellet was redissolved in 15 ml 
equilibration buffer. 
The sample obtained from three-phase partitioning was loaded onto a Sephadex G-IOO column 
(5 x 17 cm = 320 ml; flow rate 75 ml/h), equilibrated with equilibration buffer. The column was 
washed with 1 column volume of equilibration buffer and the adsorbed material was eluted with 
0.25% maltose in equilibration buffer. Fractions corresponding to the active peak were pooled 
and concentrated by dialysis against PEG 20 000. 
3.4.2.3 Results 
The purification of acid a-glucosidase is summarized in Table 5. 
Table 5. Purification of acid a-glucosidase from porcine liver 
Total Total Specific Purifi-
Vol. protein activity activity cation Yield 
(ml) (mg) (units) (units/mg) (fold) (%) 
Homogenate 725 55522 613 .35 0.011 (1) (100) 
Acid Ppt. 480 16604 386.08 0.023 2.09 63 
TPP (15-25%) 14.5 618.5 195.65 0.316 28 .72 32 
Sephadex G-l 00 30.4 2.004 35 .17 17.55 1595.5 0.06 
This method proved to be highly reproducible and very quick. TPP fractionation of the acid 
supernatant provided an enriched fraction which was subsequently separated by affinity 
chromatography on Sephadex G-100 (Fig. 10). A very large peak of unbound material eluted , 
while a small acid a-glucosidase active peak eluted after the addition of maltose to the elution 
buffer. 
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Figure 10. Affinity chromatography of the pH 4.2 TPP fraction of porcine liver acid a-glucosidase on 
Sephadex G-IOO. 
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Column; 5 x 17 cm (334 rnl bed volume), equilibrated in 20 mM Na-acetate, pH 5.8, containing 0.02% 
NaN3 and eluted with 20 mM Na-acetate, pH 5.8, containing 0.25% maltose and 0.02% NaN3 applied 
at -l..; flow rate, 75 rnlIh (3 .8 cm/h); fractions, 7.5 rnl (6 min). (-) A18Q; ( ... ) acid a-glucosidase activity 
(units), (H) pooled fraction. 
The progression of the isolation was analysed by reducing Tris-glycine SDS-PAGE (Fig. 11). 
Lanes c and d show the supernatants after acid precipitation and TPP" Note the degree of 
purification achieved after the TPP step and the concomitant disappearance of the very prominent 
band corresponding to haemoglobin. Acid a-glucosidase was purified as a mixture of the higher 
(74 kDa) and the lower molecular weight forms (66 kDa) and the double protein band is clearly 
visible in lane e of Fig. 11 . 
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Figure 11. Reducing Tris-glycine SDS-PAGE of acid a.-glucosidase fractions isolated from bovine liver. 
Samples were boiled in reducing treatment buffer and loaded onto a 7.5% glycine gel. (b) Homogenate 
fraction; (c) acid precipitate supernatant; (d) TPP fraction; (e) Sephadex G-I00 fraction; and (a, f) 
MW markers (Phosphorylase b, Mr 97 000; BSA, Mr 68 000; ovalbumin, Mr 45 000; carbonic 
anhydrase, Mr 30 000). Visualised using Coomassie Blue R-250. 
3.4.3 Production of anti-bovine liver acid a-glucosidase antibodies 
3.4.3.1 Reagents 
Freund' s complete and incomplete adjuvant. Freund' s adjuvants were from Difco, Mi., USA. 
3.4.3.2 Procedure 
Antibodies against bovine liver acid a-glucosidase were raised in rabbits by immunising rabbits 
subcutaneously at 2 sites on the back, with a total of 100 J..Lg of bovine liver acid a-glucosidase 
emulsified in a 1: 1 ratio with Freund' s complete adjuvant. Further inoculations were 
administered, in the same manner, in Freund ' s incomplete adjuvant, using the same dose, after 
two weeks and then at 4-week intervals. Blood was collected from the marginal ear vein at 7, 9 
and 12 weeks and rabbit anti-sheep liver a-glucosidase (IgG) antibodies were purified from the 
serum by precipitation with PEG (Section 2.7.2) . The antibodies were partially characterized by 
ELISA (Section 2.7.3). 
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3.4.3.3 Results 
ELISA analysis showed that the antibody level was relatively high at week 7, and increased by a 
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Figure 12. ELISA of the progress of immunisation of rabbits with bovine liver acid a-glucosidase. 
Bovine acid a-glucosidase was coated at 1 Ilglml, incubated with serial two-fold dilution of rabbit 
anti-bovine acid a-glucosidase antiserum followed by sheep anti-rabbit IgG-HRPO (Section 2.9). 
Antiserum from weeks 7 (e), 9 (0), 12 (.) and pre-immune (M . 
3.5 Discussion 
The isolations of cathepsins S and B and acid a-glucosidase were undertaken for further studies 
on the effect of the reducing agent cysteine on their activity (Chapter 4). The isolation protocols 
of cathepsins Sand B were extensively modified from those previously reported, and were aimed 
at streamlining the isolations and making them more cost effective. Cathepsin S, which is the 
least studied of the three enzymes, was also further characterized, while acid a-glucosidase was 
also used as a source of immunogen for the preparation of antibodies for possible further 
immunochemical and immunocytochemical studies. 
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Isolation of cathepsin S 
All other published procedures for cathepsin S purification appear to be more labour and time 
intensive than that developed in this study. The most commonly used method of Kirschke et al. 
(1986; 1989), and the slightly modified version ofKirschke and Wiederanders (1994), involve the 
following steps to yield an electrophoretically pure sample: overnight autolysis at 4°C (Kirschke 
et aI. , 1986) or 1 h autolysis at 40°C (Kirschke and Wiederanders, 1994), ammonium sulfate 
fractionation, overnight dialysis, ion exchange and molecular exclusion chromatography, covalent 
chromatography (Kirschke et aI. , 1986) or chromatofocusing (Kirschke and Wiederanders, 
1994), hydrophobic and ion exchange chromatography. Dolenc et al. (1992) and Maciewicz and 
Etherington (1988) have also developed cathepsin S isolation procedures which differ from the 
above procedures but also comprise a large number of time consuming and costly steps. With 
the aim of reducing the length and cost of cathepsin S isolation, yet still obtaining an acceptable 
yield, a number of different approaches were explored, leading to the final purification protocol 
reported here. 
Firstly, the autolysis step was by-passed as no apparent increase in yield could be found and it 
was felt that after homogenisation of the spleen and the release of active proteinases it may do 
more damage than good. The ammonium sulfate fractionation step was replaced with TPP, 
which has been successfully employed in the rapid isolations of both cathepsin L (pike and 
Dennison, 1989) and D (Jacobs et aI. , 1989). One advantage of TPP is that the resulting fraction 
has a much lower salt concentration than after ammonium sulfate fractionation (pike and 
Dennison, 1989), and can therefore be applied directly to an ion exchange column, without a 
prior desalting step. Ion exchange and molecular exclusion chromatography steps were used 
essentially as described by Kirschke et al. (1989) except that S-Sepharose and Sephacryl S-100 
were used instead of CM-Sephadex C-50 and Sephacryl S-200. Two peaks of cathepsin S-like 
activity eluted from Sephacryl S-100 (Fig. 3), one at a much higher molecular weight, which has 
been noted before by Xin et al. (1992). They concluded that the high Mr fraction consisted of 
cathepsins Band S noncovalently associated with other proteins. Analysis of the Sephacryl 
S-IOO fraction on SDS-P AGE (Fig. 5) . showed only three bands of protein still remaining, so a 
single step was sought to remove the two contaminating proteins. A variety of techniques were 
explored, including preparative isoelectric focusing and Resource S high resolution ion exchange 
chromatography. None of these removed both the contaminant proteins. Finally hydroxyapatite 
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was used and the contaminate proteins passed through giving an inactive breakthrough peak, 
while a cathepsin S active fraction was eluted using a step gradient (Fig. 4) . This fraction proved 
to be electrophoretically pure (Fig. 5). 
Analysis of the pure enzyme on Tris-tricine SDS-PAGE (Fig. 5) showed a band corresponding to 
Mr 12 000, which was exactly half the value previously reported for the enzyme on Tris-glycine 
SDS-P AGE (Kirschke et aI. , 1986; 1989; Xin et aI. , 1992). However, the purified cathepsin S 
sample was subsequently run on a calibrated Sephacryl S-100 column and eluted at Mr 20 000 
which was the same as previously reported (Kirschke et al., 1989; Kirschke and Wiederanders, 
1994). Therefore, it was concluded that cathepsin S showed anomalous behaviour on Tris-tricine 
SDS-PAGE. The sample was run on Tris-glycine SDS-P AGE, but resolution was not good 
enough at the lower molecular weight range so the molecular weight of the cathepsin S fraction 
could not be accurately assessed. 
This isolation protocol employed fewer steps than any previously reported and also used cost 
effective techniques. For example, the three chromatographic steps used are less expensive than 
chromatofocusing (Kirschke et al. , 1989; Kirschke and Wiederanders, 1994) which uses 
expensive polybuffers and also requires a further hydrophobic chromatography step to remove 
the polybuffer from the cathepsin S fraction . Xin et al. (1992) also showed that the ampholines 
may become irreversibly adsorbed to cathepsin S. The fact that fewer steps were used to isolate 
the enzyme means that it was in contact with other potentially damaging enzymes for the shortest 
possible time and so there is less chance that artefacts, created by enzyme digestion, could occur. 
The effectiveness of each step used in this purification can be assessed by looking at what each 
achieved. TPP not only gave a low salt fraction, so eliminating the need for a dialysis step, but 
with the TPP protocol being optimised for cathepsin S a very selective fraction was obtained. 
The following cation exchange step was crucial for the removal of cathepsins Hand L which both 
eluted later than cathepsin S. Molecular exclusion removed cathepsin B, which eluted just before 
cathepsin S. This sample only contained cathepsin S activity, but SDS-PAGE analysis indicated 
two contaminating proteins. These were removed using hydroxyapatite chromatography, which 
showed specific affinity for cathepsin S. 
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The yield of cathepsin S from bovine spleen (0.2 mglkg) was lower than that reported by 
Kirschke et al. (1989), Dolenc et al. (1992) and Kirschke and Wiederanders (1994), who 
recovered between 1 and 3 mg/kg, but was very similar to those of Kirschke et a!. (1986) and 
Xin et al. (1992) (0.2 to 0.4 mg/kg) . The speed and cost effectiveness of this protocol was 
considered to be an acceptable trade-off for reduced yields. One of the main reasons for a low 
yield was the molecular exclusion chromatography step. In other purification protocols it has 
been reported that cathepsin Sand B elute together on both the ion exchange and molecular 
exclusion columns (Kirschke et a!. , 1989). However, in this protocol it was possible to separate 
these two enzyme activities by molecular exclusion by changing from Sephacryl S-200 to 
Sephacryl S-100, which is better able to separate lower molecular weight proteins. The activities 
of cathepsin Sand B eluted close together; therefore, in order not to contaminate the sample a 
very selective fraction was taken, thus reducing the yield of cathepsin S. 
One property of cathepsin S by which it was thought to differ from all other lysosomal cysteine 
proteinases is in its stability at neutral pH values (Kirschke et al., 1989). However, recently this 
supposed defining characteristic of cathepsin S has been shown to be less definitive with the 
discovery that the stability of cathepsin B is affected by its activation state and by the buffer ionic 
strength (Dehrmann et a!. , 1995; 1996; Turk et al., 1994). Previously it was reported that 
cathepsin B exhibited optimal activity in slightly acidic media (pH 6.0) (Barrett and Kirschke, 
1981). Dehrmann et a!. (1996), however, showed that previous pH profiles of cathepsin B did 
not take into consideration the effect of ionic strength on the activity of the enzyme over a pH 
range. They showed that ionic strength had a marked effect on enzyme stability and activity, and 
that this was affecting the apparent pH activity profile. If the molarity of, say, a phosphate buffer 
is kept constant, then the ionic strength will increase with pH, as shown by the Henderson-
Hasselbalch equation, 
- ~ 
pH - pKa + log [acid] 
where the ionic strength is a function of [ salt] . Increasing ionic strength lowers the stability and 
activity of cathepsin B, and the apparent pH optimum and pH stability is thus biased towards the 
low side in anionic buffers of constant molarity. Cathepsin B activity measured in the presence of 
a constant ionic strength buffer showed an optimum of pH 7-8 (Dehrmann et a!. , 1996). 
Therefore, the pH activity profile of cathepsin S was determined in the pr:.esence of constant ionic 
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strength buffers to see if this changed the pH profile from those reported. The results indicate an 
optimum of pH 6.5 which was similar to previous reports (Kirschke et aI. , 1989; Kirschke and 
Wiederanders, 1994). However, the enzyme showed greater stability over the pH range as it was 
still over 50% active at both pH extremes, whereas Kirschke et al. (1989) showed an almost 
complete loss of enzyme activity at these pH values (Fig. 6). 
The percentage of active enzyme in the purified sample, revealed by titration with E-64, showed 
that the cathepsin S preparation contained 42% active enzyme molecules. This compares well 
with the results of Kirschke and Wiederanders (1994) who reported 30 to 40% active enzyme. 
However, with the inclusion of an affinity chromatography step (activated thiol-Sepharose 4B or 
activated thiopropyl-Sepharose 6B), Kirschke and Wiederanders (1994) removed the inactive 
molecules and the resulting preparation was 100% catalytically active. 
Km (3 .91 !J.M) and Vmax (5,39 !J.M.S-1) were determined using the direct linear plot of Eisenthal 
and Cornish-Bowden (1974) (Section 3.2.5). Km is characteristic of an enzyme/substrate couple 
and thus can be used to identify a particular enzyme. V max varies with the total concentration of 
enzyme present and so is, by itself, not very useful. The constant kcat, called the turnover 
number, is often applied to enzyme catalysed reactions. It represents the maximum number of 
substrate molecules which can be converted to products per molecule enzyme per unit time and 
can be derived from V max and [Eo] values. The turnover number, kcat, was calculated to be 2.9 S-l . 
These results differ somewhat from those of Bromme et al. (1989), who reported a Km value of 
8.1 !J.M and kcat of 13 S-l for bovine cathepsin S. However, their assay conditions differed, in 
activation time and heat treatment of the enzyme, from those used in this study. 
Isolation of cathepsin B 
Cathepsin B has been purified using a variety of isolation protocols. Barrett and Kirschke (1981) 
described two different methods, one for human liver and the other for rat liver cathepsin B. 
However, these protocols used a large number of steps which included specific covalent 
chromatography steps. A more recent protocol described by Rich et al. (1986), which was 
widely used, also contains a specific isolation step, use of the affinity resin Agarose-Ahx-Gly-
Phe-Gly-Sc, but this resin is no longer commercially available. A co-purification of four 
cathepsins including cathepsin B has been developed by Maciewicz and Etherington (1988) using 
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a number of specific and expensive column chromatographic steps on an FPLC system. So a 
simple purification method which did not contain such limiting factors, was needed. 
The purification of cathepsin S in this study gave insight into a possible cathepsin B isolation 
procedure. Monitoring of the cathepsin B activity during the cathepsin S isolation procedure 
showed that it eluted from S-Sepharose in the same fraction as cathepsin S, whereas on 
Sephacryl S-100 the cathepsin Sand B activities separated. This fact, and that the cysteine 
proteinases cathepsins Land H had been removed in the ion exchange step, led to the cathepsin S 
protocol being considered a suitable starting point for a cathepsin B isolation. The TPP cut was 
optimised for cathepsin B, followed by the same ion exchange (Fig. 7) and molecular exclusion 
chromatographic steps (Fig. 8) as used for the isolation of cathepsin S. The cathepsin B activity 
which eluted from Sephacryl S-100 was found to be electrophoretically pure (Fig. 9). In this 
study a co-purification of cathepsins S· and B was performed as the optimal cathepsin Sand B 
TPP cuts only overlapped slightly and, by taking a narrower cathepsin B cut, the two enzymes 
could be purified from the same starting material. In this procedure the optimal cathepsin S TPP 
cut of 15 to 30% was used and a 30 to 40% TPP cut for cathepsin B, although, the optimal TPP 
cut for cathepsin B was 25 to 40%. Thus, a higher yield of cathepsin B could be obtained from 
this procedure if it was not done in conjunction with the cathepsin S isolation. A purification of 
cathepsin B was carried out using this optimum procedure, but the results are not shown here. 
The yield of cathepsin B, which was obtained from the dual purification, was low (Table 4), but, 
as explained above this was a trade-off for the easy and quick method by which it was isolated. 
Cathepsin B was isolated purely for further studies to be described in Chapter 4, so quantity was 
not as essential as the need for easily obtainable, pure enzyme. This cathepsin B purification 
protocol does not contain any techniques which select specifically for the enzyme, such as affinity 
chromatography and, therefore, the purity of the sample can be easily affected by small changes 
in any of the techniques used. For example, if the TPP cut is varied the subsequent purification 
techniques may be unable to remove the different contaminants. This is also true when selecting 
fractions to pool from the ion exchange step, as the contaminants picked up by pooling too broad 
an activity peak may also not be removed in the following molecular exclusion step. The 
fractions from the molecular exclusion step were assayed on SDS-P AGE before being pooled so 
as to minimise contamination. 
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Isolation of acid a.-glucosidase 
Current published procedures for the isolation of acid a.-glucosidase almost all incorporate 
Sephadex G-I00 affinity chromatography. This technique was first discovered when acid 
a.-glucosidase activity was observed to be ' retarded' on dextran-type gels and it was realised that 
this would constitute a method of separating acid a.-glucosidase from other proteins of similar 
molecular weight that were not retarded (Auricchia and Bruni, 1967). Retardation of acid 
a.-glucosidase on dextran-type gels, which contain a.-linked glucose units, is due to the gel acting 
as a substrate analogue (Auricchio et aI. , 1968). Due to the consequent affinity between the 
enzyme and the gel, the enzyme elutes later than one column volume, though in a broad peak. 
However, addition of a competing substrate to the elution buffer, after one column volume, 
causes the enzyme to elute in a sharper peak of activity (Tashiro et al., 1986). 
The protocol used in this study was a modification of that of Tashiro et al. (1986). This 
commonly used method involves the preparation of a lysosomal extract, ammonium sulfate 
fractionation and Sephadex G-I00 affinity chromatography. The method is neither costly nor 
time consuming, but slight modifications were made to streamline the procedure. The 
preparation of a lysosomal extract was by-passed as it did not increase the yield of enzyme, and 
was a relatively time consuming procedure. However, an acid precipitation step was added as 
this was quick and removed a large portion of contaminating proteins, thus increasing the 
effectiveness of the following TPP step. TPP, which was optimised for acid a.-glucosidase, was 
used in place of ammonium sulfate fractionation so that the sample could be directly applied to 
the Sephadex G-I00 affinity column, without a prior desalting step. The acid a.-glucosidase 
activity was subsequently eluted using maltose in the buffer (Fig. 10). Acid a.-glucosidase has a 
higher affinity for maltose than for the dextran gel so by adding it to the elution buffer the 
enzyme preferentially binds maltose, and thus no longer interacts with the Sephadex G-IOO 
column. 
The yield of acid a.-glucosidase (6.7 mglkg) was very similar to that of Tashiro et al. (1986) 
(5.4 mglkg) so the changes made to their protocol, if anything, improved the yield. This, on its 
own, vindicates the removal of the lysosomal extract step used by Tashiro et al. (1986) and 
underscores the effectiveness of TPP as a fractionation technique. Therefore, the isolation of 
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acid a-glucosidase has been further streamlined in time rather than in a reduction in the number 
of steps, with a resulting increase in yield of enzyme. 
The purified sample of acid a-glucosidase contained two distinct components at 74 kDa and 
66 kDa on SDS-PAGE (Fig. 11). Hasilik and Neufeld (1980 a,b) purified the enzyme from 
human placenta and also found two components, with molecular masses of 76 kDa and 70 kDa. 
Tashiro et al. (1986) reported that acid a-glucosidase purified from pig liver contained two 
components. Nakasone et al. (1991) studied the heterogeneity of pig lysosomal acid 
a-glucosidase by isolation of the enzyme from different organs, and separated the enzyme 
activities using their differing affinity for Sephacryl S-200. They concluded that the different 
molecular weight components may originate from different cells, as the macrophage enzyme 
seemed to consist of only a 76 kDa component and the hepatocyte enzyme of both 76 kDa and 
67 kDa components. However, the question arises as to whether the 67 kDa molecule represents 
a normal mature form of the enzyme. From amino acid analysis of the 76 kDa and 67 kDa 
components, the 67 kDa molecule was considered to be a product of the 76 kDa mature form 
(Nakasone et al., 1991). Nakasone et al. (1991) concluded that in macrophages, which contain 
only a 76 kDa component, the processing or degradation of acid a-glucosidase is different from 
that in other cells. 
Following the successful isolation of acid a-glucosidase, the objective was to raise anti-acid 
a-glucosidase antibodies that would be suitable for immunocytochemical studies of the enzyme. 
Acid a-glucosidase was able to elicit an immune response in rabbits (Fig. 12). The enzyme 
elicited a fairly rapid immune response, this being fairly high after 7 weeks and subsequently only 
increasing slightly up to 12 weeks. An attempt was also made to raise antibodies in chickens, but 
both chickens died during the inoculation procedure. This could be due to an auto-immune 
response, but this would have to be studied further. The anti-acid a-glucosidase antibodies 




LYSOSOMAL REDOX POTENTIAL 
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The intralysosomal cysteine/cystine ratio, and thus the redox potential that this generates, may in 
part regulate lysosomal function in the cell (Chapter 1). However, there are a number of 
questions surrounding this hypothesis. Firstly, whether cysteine is in fact the intralysosomal 
reducing agent (Lloyd, 1986) and, ifit is, is the cysteine/cystine ratio within the lysosome actively 
regulated by specific membrane transporters (pisoni et al., 1990) or is their ratio maintained by 
cysteine and cystine molecules liberated from protein breakdown (Lloyd, 1986; 1992). Secondly, 
what is the effect of varying cysteine concentrations on lysosomal cysteine proteinases, in this 
case especially cathepsins B, Land S, and the lysosomal enzyme responsible for glycogen 
hydrolysis, acid a-glucosidase? 
Observations on the metabolic disease cystinosis, characterized biochemically by a high cystine 
concentration in the lysosomes and nonnal concentrations in the cytoplasm and extracellular 
fluids, provided some insight into the identity of the intralysosomal reducing agent. The cystine 
of cystinotic fibroblasts may be depleted by incubation in vitro with the thiol cysteamine, and it 
was found that the rate of re-accumulation of cystine correlates with the presence of cystine-
containing proteins in the culture medium (Thoene and Lemons, 1982). This and earlier evidence 
(Thoene et al., 1977; Thoene and Lemons, 1980) indicates that cystine accumulates in lysosomes 
of cystinotic cells as a consequence of lysosomal digestion of exogenous and/or endogenous 
cystine containing proteins. This data on cystinotic cells was consistent with the metabolic defect 
being one of cystine reduction, perhaps through an under-production of the physiological 
reducing agent (Kooistra et ai., 1982). Further work, however, showed that the defect in 
cystinosis is the absence of a cystine-transport system, nonnally present in the lysosomal 
membrane (Kooistra et ai. , 1984; Smith et ai., 1987). Thus, cystine leaves nonnallysosomes as 
cystine, without prior reduction to cysteine (Lloyd, 1986). 
Mego (1984) drew attention to a paradox presented by these results. If cystine residues in 
proteins are reduced during proteolysis (Chapter 1), why do cells need a cystine-transport system 
67 
in the lysosomal membrane and why does its absence (in cystinosis) cause profoundly elevated 
intralysosomal concentrations of cystine? Lloyd (1986) suggested the resolution of this paradox 
lay in the identity of the reducing agent responsible for intralysosomal reduction. The first 
candidate is cysteamine (Thoene et al., "1976; Kooistra et a!. , 1982). This substance is a normal 
component of the cytoplasm, albeit in low concentration, is able to cross the lysosomal membrane 
in both its reduced and oxidised (cystamine) forms (Kooistra et a!. , 1982), and reduces cystine in 
cystine-loaded isolated lysosomes (Gahl et a!. , 1985). However, this hypothesis fails to explain 
why cystine accumulates in cystinotic cells, as cysteamine is present in normal concentrations in 
these cells (Orloff et al. , 1981). The second candidate for physiological reductant is reduced 
glutathione (GSH). However, it appears that GSH cannot cross the lysosomal membrane (Mego, 
1984; Gahl et a!. , 1985). A third candidate, cysteine, is abundant in the cytoplasm and can 
penetrate the lysosomal membrane in normal and cystinotic cells (Kooistra et a!. , 1982; Gahl 
et al. , 1982). Cysteine may also arise in the lysosomes by degradation of cysteine-containing 
proteins (Lloyd, 1986). Like any other thiol, it could by two sequential reactions fully reduce a 
protein cystine residue, but unlike other reductants would in the process generate a molecule of 
cystine. This cystine, arising not from the protein itself but from the reductant, would still require 
a cystine transporter for efllux from the lysosome. 
The above observations not only provide a strong case for cysteine being the intralysosomal 
reducing agent, but also for the existence of a lysosomal membrane cystine-transporter for efllux 
of cystine from the lysosome. Following the development of the above argument, Pisoni et a!. 
(1990) discovered a cysteine-specific lysosomal transport system which they claim provides a 
major route for the delivery of cysteine into the lysosomal compartment. Therefore, it appears 
that the lysosomal membrane may contain two highly specific transport systems, which Pisoni 
et al. (1990) concluded were involved in regulating the flow of cystine and cysteine between the 
intralysosomal space and the cytosol (Fig. 13). However, Lloyd (1992) disagreed with the 
conclusion drawn by Pisoni et al. (1990) and argued, from the stoichiometry of the reduction 
reaction, that there is no need for the net import of cysteine into lysosomes for proteolysis. 
Lloyd (1992) proposed that if the reducing agent is free cysteine, the cysteine consumed will be 
exactly balanced by the cysteine liberated when the disulfide moieties in the protein are reduced 
and its peptide linkages hydrolysed by the cathepsins. There will also be an equivalence between 
the cystine content of proteins entering the lysosomes by endocytosis or autophagy and the 
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cystine released from the lysosomes via the cystine porter. Lloyd (1992) therefore concluded 
that there is no requirement for a net influx of cysteine and if there was an inward flow it is likely 
to constitute an anapleurotic pathway, serving only to maintain the cysteine concentration within 
lysosomes by replacing any cysteine that undergoes autoxidation to cystine. Lloyd (1992) 
implied that this does not weaken his argument (Lloyd, 1986) that cysteine is the physiological 
reducing agent for disulfide reduction in lysosomes, but that direct experimental evidence is still 
lacking. If the role of the cysteine transporter is not to provide cysteine as an aid to disulfide 
reduction concomitant with proteolysis, might its role be to modulate the intralysosomal redox 
potential, and thereby also the activity of lysosomal enzymes, especially proteinases? 
It seems possible that lysosomal proteolytic activity may be regulated by changes in the lysosomal 
thiol-disulfide status. It may be observed that the two known transporters are thought to operate 
in the same sense in terms of altering the intralysosomal redox potential (Fig. 13), i.e. importing 
cysteine will favour reduction by increasing the cysteine/cystine ratio, and exporting cystine will 
have a similar effect. Presumably balancing this is a net import of cystine into the lysosome in the 
form of imported proteins and the possible efflux of cysteine through systems e and f (pisoni 
et a/. , 1990). A decreased cysteine/cystine transporter activity would lead to an increase in redox 
potential and a concomitant slowing of proteolysis (and glycogenolysis). Moreover, for each unit 
increase in pH, E'o becomes more negative by 0.059 volts (i.e. E'o = Eo - 0.059pH) (Segel, 1976), 
thus an increase in pH will increase the reducing potential at a given cysteine/cystine ratio. Thus, 
the activity of lysosomal enzymes may be regulated by both pH and redox potential and possibly 
their interaction. The intralysosomal redox potential may thus constitute part of a regulatory 
mechanism with links to the lysosomal pH and the cellular ATP/ADP status perhaps via an 
ATPase proton pump, amongst others. 
Determination of the in vivo redox potential of lysosomes and the possibility that this potential 
may vary, poses a number of experimental difficulties. Redox states of cerebral mitochondria 
during metabolic stress have been determined (Vannucci and Brucklacher, 1994) using the 
NAD+/NADH ratio as a reflection of the redox state, but this approach is not applicable to 
lysosomes. Lysosomes have not been reported to have intrinsic redox reporter molecules such as 
NAD+. Consequently, in this study, use was made of an exogenous, lysosomotropic, redox-
sensitive, fluorescent dye. 
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Figure 13 . Schematic diagram showing (1) the interconversions between cystine and cysteine in different cellular 
compartments, (2) the role of transport systems in maintaining this cycle, (3) and the role of cysteine 
in supporting lysosomal proteolysis. Systems e and f possibly facilitate lysosomal cysteine exodus. 
Shaded area represents the cytosol and the clear area represents the lysosomal compartment (adapted 
from Pisoni et al., 1990). 
The effect of cysteine on the lysosomal cysteine proteinases may give insight into how lysosomal 
proteolytic activity may respond to different redox potentials. It is known that in their isolated 
forms the cysteine cathepsins require activation with a reducing agent, such as cysteine, before 
they manifest proteolytic activity. Whether this is true of the enzymes in vivo is, to my 
knowledge, an open question. The response of acid a.-glucosidase to reducing conditions, 
especially in the context of its role in glycogen turnover, may also be relevant, as the rapid 
breakdown of glycogen could be initiated by reduction (Chapter 1). The possible effect of 
cysteine concentration on the activity of acid a.-glucosidase might cast light on the question of 
whether redox potential affects lysosomal enzymes in general, or only the cysteine cathepsins. 
This chapter involves assessing the effect of cysteine on the activity of the three lysosomal 
enzymes isolated as described in Chapter 3, followed by qualitatively determining the in vivo 
intralysosomal redox potential using specific fluorescent dyes. 
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4.2 Materials 
Cell culture components, including insulin, hydrocortisone, Penicillin G/Streptomycin (10 000 
units and 10 mg/ml, resp.), Dulbecco' s Minimal Essential Medium (DMEM): Hams F-12 
Medium, trypsin-EDTA solution (Xl), Hanks balanced saline solution (HBSS), and cysteine.HCl 
were from Sigma Chemical Co., St Louis, Mo. USA; Fungizone (250 Ilg/ml) and horse serum 
were from Gibco, Paisley, UK, and epidermal growth factor (EGF) was from Upstate 
Biotechnology Incorporated, Lake Placid, NY USA. LysoTrackerTM Red and C-2938 were from 
Molecular Probes Inc. , Europe BV. 
4.3 The effect of cysteine concentration on three lysosomal enzymes 
The effect of increasing cysteine concentrations on the lysosomal cysteine proteinase cathepsin L 
has previously been described by Dennison et al. (1992) (Fig. 16). To similarly determine the 
effect of cysteine concentration on cathepsins S and B and acid a-glucosidase, activity was 
assayed against their specific artificial substrates in the presence of a constant ionic strength 
buffer containing a range of cysteine concentrations. The assay buffers had constant ionic 
strength to remove the possible effect this could have on activity, and was achieved by balancing 
the ionic strength of the cysteine in each buffer with sodium chloride. The assay used for 
cathepsins S and B was a modification of that of Barrett and Kirschke (1981), and for acid a-
glucosidase a modification of the method of Geddes and Taylor (1985a). 
4.3.1 Cathepsin S assay 
4.3.1.1 Reagents 
Buffer/activator [0.1 M K-phosphate, 5 mM Na2EDTA 0 - 200 mM cysteine, pH 6.5]. The 
buffers were made up to 4/3 times the final (nominal) concentration to accommodate dilution in 
the assay. KH2P04 (0.91 g), N a2EDT A (0. 12 g) and the appropriate amounts of cysteine and 
NaCI were dissolved in 40 ml dist.H20 , adjusted to pH 6.5 with NaOH and made up to 50 ml. 
The buffers were stored in light-proof bottles under nitrogen. These buffers were always made 
up immediately prior to use. 
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10 mM Bz-Phe-Val-Arg-NHMec substrate stock solution. Bz-Phe-Val-Arg-NHMec (7.18 mg) 
was dissolved in DMSO (1 mI), split into 50 ~l aliquots and stored at _4°C. When required, it 
was diluted to a working strength of34 ~ (27 ~l to 8 mI). 
Diluent [0.01% Triton X-lOO, 0.1 M K-phosphate, 1 mM Na2EDTA pH 6.5]. Triton X-lOO 
(10 ~l) , KH2P04 (1.36 g) and Na2EDTA (0.19 g) were dissolved in 95 mI dist.H20, adjusted to 
pH 6.5 with KOH and made up to 100 mI. 
4.3.1.2 Procedure 
The assay was carried out in assay buffer/activator containing a range of cysteine concentrations, 
0, 12.5, 25, 50, 75, 100, 150, 200 mM (final concentration) with NaCI being added so that the 
buffers had equivalent ionic strengths (i.e. [cysteine] + [NaCl] = 200 mM). All solutions were 
equilibrated to 37°C, except the diluted enzyme solution which was kept on ice. Each assay 
consisted of 750 ~l buffer/activator and 1 00 ~l of appropriately diluted enzyme. This was 
activated for 2 min at 37°C, followed by the addition of 150 l.tI of the substrate solution. The 
change in fluorescence was measured continuously at 37°C in a temperature-controlled Hitachi 
F-2000 recording spectrofluorometer, with excitation at 370 nm and emission at 460 nm. Data 
was sampled at 10 sec intervals over a 10 min period and activity was determined from the slope 
of the plot of fluorescence intensity versus time. This was expressed in terms of a percentage of 
the maximal activity. 
4.3.2 Cathepsin B assay 
4.3.2.1 Reagents 
Buffer/activator [0.1 M Na-phosphate, 4 mM Na2EDTA 0-200 mM cysteine, pH 6.0]. The 
buffers were made up to 4/3 times the final (nominal) concentration to accommodate dilution in 
the assay. NaH2P04 (6.90 g), Na2EDTA (0.93 g) and the appropriate amounts of cysteine and 
NaCI were dissolved in 40 mI dist.H20 , adjusted to pH 6.0 with NaOH and made up to 50 mI. 
The buffers were stored in light-proof bottles under nitrogen. These buffers were always made 
up immediately prior to use. 
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1 mM Z-Arg-Arg-NHMec substrate stock solution. Z-Arg-Arg-NHMec (1.1 mg) was dissolved 
in DMSO (1.5 ml), split into 100 ~l aliquots and stored at -4°C. Just before use the stock was 
diluted to 40 ~ with dist.H20 (0.1 ml to 2.5 ml). 
Diluent [0.1% Brij]. Brij (O.lg) was dissolved in 95 ml dist.H20, and made up to 100 ml. 
4.3.2.2 Procedure 
The procedure was the same as described for cathepsin S (Section 4.3.1.2). 
4.3.3 Acid a-glucosidase assay 
4.3.3.1 Reagents 
Buffer/activator [0.1 M Na-acetate. 0-200 mM cysteine. pH 4.5]. The buffers were made up to 
4/3 times the final (nominal) concentration to accommodate dilution in the assay. Glacial acetic 
acid (3 .81 ml) and the appropriate amounts of cysteine and NaCI were dissolved in 40 ml 
dist.H20 , adjusted to pH 4.5 with NaOH and the volume made up to 500 ml. The buffers were 
stored in light-proof bottles under nitrogen. These buffers were always made up immediately 
prior to use. 
20 mM 4-methylumbelliferyl-a-glucoside stock solution. 4-methylumbelliferyl-a-glucoside 
(0.067 g) was dissolved in 10 ml of dist.H20 , split into 500 ~l aliquots and stored at -4°C. When 
required, it was diluted to a working strength of 0.2 mM with dist.H20 (0.1 ml to 10 ml). 
4.3.3.2 Procedure 
The procedure was the same as for cathepsin S (Section 4.3.1.2), except the change in 
fluorescence for the 4-methylumbelliferyl-a-glucoside substrate was measured with excitation at 
365 nm and emission at 450 nm. 
73 
4.4 Qualitative measurement of the redox potential of acidic compartments in vivo 
The measurement of lysosomal redox potential within cultured cells requires a redox indicator 
system which can penetrate the cell membrane, accumulate specifically in lysosomes, and remain 
there to give a quantitative indication of their redox status. However, no single indicator system 
meets all these criteria. Therefore, in order to study lysosomal redox potential, a double labelling 
system was devised. For detecting intralysosomal oxidation the cells were loaded with the 
acetoxymethyl ester derivative, 5-( and-6)-carboxy-2', 7'-dichlorodifluorescein diacetate, 
bis(acetoxymethyl) ester (Molecular Probes, C-2938). This dye is membrane permeable and after 
hydrolysis forms a carboxyfluorescein, which fluoresces in the oxidised form (Fig. 14). C-2938 
is, however, not selectively loaded into lysosomes, but may also accumulate in other intracellular 
organelles such as mitochondria. Lysosomes can, however, be visualized using a second dye, 
LysoTracker Red (Molecular Probes, L-7528) (I), which is a membrane permeable, acidotropic 
probe for labelling and long-term tracing of acidic organelles in living cells. Acidotropic probes 
selectively accumulate in cellular compartments with low internal pH. Using this double labelling 
system, the intralysosomal oxidation status in cultured cells may be visualized (This system was 
devised in conjunction with Dr A.M.C. Dreijer, Technical assistance representative, Molecular 















I = C400 bis-acetoxymethyl ester 








I I = 5- (and-6)-carboX?'-2',7'-dichlorodihydrotluorescein diacetate 






III = 5-(and-6)-carboxy-2',T-dicblorofluorescein 
(Molecular Probes Catalog No. C-368) 
C-OH 
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I V = 5-(and-6)-carboxy-2', T-dicblorofluorescin 
Figure 14. Molecular Probes Inc. C-2938 dye for detecting intraiysosomai oxidising conditions. 
C-2938 (I) is a bis-acetoxymethyl ester of C400 (II). Unlike C400, it is therefore uncharged and is 
thus membrane permeable. Intraiysosomai esterases will hydrolyse the esters thereby trapping the dye 
in the organelle and concurrently generating the redox sensitive fluorophores (m ) and (IV). 
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4.4.1 Emission profiles of LysoTracker and C-2938 
The emission profiles of LysoTracker and C-2938 dyes were examined, firstly to see if the 
excitation wavelengths of the epifluorescent microscope would generate a suitable emission 
profile, as they were not the precise excitation wavelengths given for these dyes. Ideally 
LysoTracker should be excited at 577 run and C-2938 at 495 run, but' the two excitation 
wavelengths available in the epifluorescent microscope were 560 run and 490 run. Secondly, the 
experiment involves loading the cells with both dyes simultaneously and therefore it was 
necessary to establish if there was interference between the spectra of the two dyes. 
4.4.1.1 Reagents 
MCF growth medium. The DMEM:Hams F-12 medium (1 : 1) was supplemented with horse 
serum [5% (v/v), 52.6 ml], EGF (20 J.!g, 0.43 ml), insulin (10 mg, 4.2 ml), antibiotics (100 mg 
Streptomycin and 100 000 units Penicillin G, 10 ml), Fungizone (0.25 mg, 1.1 ml) and 
hydrocortisone (0.5 mg, 2.14 ml). 
1 mM LysoTracker Red stock solution. LysoTracker dye was obtained as a 1 mM stock solution 
and was stored at -4°C. 
7.4 mM C-2938 oxidative probe stock solution. C-2938 (5 mg) was dissolved in DMSO (1 ml), 
aliquoted (50 J.!l) and stored in the dark at -20°C. 
4.4.1.2 Procedure 
The individual emission profiles ofLysoTracker and C-2938 were examined by exciting each dye 
at the wavelength of the appropriate epifluorescent microscope filter. LysoTracker (2 J.!l) and 
C-2938 (2 J.!l) stock solutions were separately diluted in MCF growth medium (1 ml) and the 
emission profiles were determined in a Hitachi F-2000 spectrofluorimeter with excitation at 560 
run for LysoTracker and 490 run for C-2938. Alternatively the two dyes were made up in the 
same solution and their emission profiles re-examined. LysoTracker (2 J.!l) and C-2938 (2 J.!l) 
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were mixed together in MCF growth medium (1 ml) and the emission profiles determined with 
excitation at 560 nm and at 490 nm. 
4.4.2 Apparatus 
Fluorescent studies .in living cells have provided new insights into cell function and the availability 
of fluorescent probes directed at specific cellular functions has paved the way for these studies. 
In many cases well defined, stable culture conditions must be maintained during intermittent or 
continuous observations. In addition, free access to cells may be required for experimental 
procedures. Versatile closed micro-chambers have been designed for fluorescent as well as light 
microscopy. Ince et al. (1983) developed a micro-CO~incubator for use on a microscope to 
study phagocytosis, cell division, cell locomotion and differentiation, but the chamber did not 
allow for easy exchange of culture medium which was essential for this study. Ince et al. (1990) 
later developed a micro-perfusion chamber for single-cell fluorescent measurements. This 
chamber was designed to accommodate glass coverslips, it was made of non-toxic materials in 
easy to assemble parts, and allowed for the rapid exchange of fluids. The micro-chamber 
developed in this study was based on that of Ince et al. (1990) design, but was simplified, as a 
number of the chambers components were not required. 
The micro-chamber was constructed in the Mechanical Instrument Workshop of the University of 
Natal, Pietermaritzburg. It consists of a perspex™ block, 70 x 30 x 8 mm, with a circular 
chamber turned out of the middle of one of the large faces. This chamber was 4 mm deep and 
had stepped sides: from the face down to 2 mm the diameter was 27 mm and from 2 to 4 mm the 
diameter was 22.2 mm. A 0.5 mm pitch thread was cut into the face from 0 to 2 mm. Opposite 
this chamber the face was relieved to a depth of 0.5 mm to provide an optically clear surface, 
protected from surface abrasion. The ' chamber was sealed with a removable 22 mm diameter 
coverslip, sandwiched between two R2075 O-rings (1116" section x 3/4" i.d.), and held in place 
by an annular perspex nut. The perspex nut was 1.5 mm thick: its outer edge was threaded with 
a 0.5 mm pitch thread, complementary to that in the chamber, and its inner edge (18 mm 
diameter) was chamfered at the same angle as the microscope objective lens. Fluid access to the 
chamber was provided by to stainless steel tubes, 1.5 mm in diameter, press-fitted into holes 
drilled in the block which intercepted 1.5 mm diameter holes drilled vertically into the floor of the 
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Figure 15. Live cell micro-chamber for fluorescent microscopy. 
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4.4.3 The MCF-IOA and MCF-IOA-:Neo-T breast epithelial ceD lines . 
The MCF-IOA and MCF-IOA-Neo-T-c-Ha-ras human cell lines are a unique pair of cell lines, 
comprised of an adherent, immortal, 'normal' breast epithelial cell line (designated MCF-I0A) 
and a transformed cell line equivalent (designated MCF-I0A-Neo-T, or simply Neo-T), derived 
from the MCF-I0A cell line, by transfection with the ras oncogene. These cell lines were 
developed at the Michigan Cancer Foundation (hence, 'MCF'), and were supplied to this 
laboratory by Dr Bonnie Sloane, of Wayne State University, Detroit USA. 
The MCF-I0 cell line is an oestrogen receptor-negative, spontaneously immortalised breast 
epithelial cell line, derived from mastectomy tissue from a 36-year-old parous, premenopausal 
woman with fibrocystic disease (Tait et aI., 1990; Soule et al., 1990). This cell line is unique as 
it is the first spontaneously immortalised line of breast epithelium, for which there is direct 
evidence that the normal diploid chromosome pattern of the original explanted tissue was 
retained for over a year in culture. Transformation to aneuploid or near diploid karyotype, 
characteristic of an immortal cell line, moreover, took place spontaneously, with minimal 
chromosome rearrangement, whereas in other currently available breast epithelial cell lines, 
immortality was induced by treatment with carcinogenic drugs, or the cell lines were transformed 
using the SV40 virus and still harbour some transforming SV40 genetic information (Soule et al., 
1990) 
The parent MCF-I0A cell line, therefore, represents the nearest to 'normal' breast epithelial cell 
line available, allowing the effect of a single oncogene transfection to be more easily discerned. 
Transformation with the ras oncogene is especially interesting. ras-Transformation of human 
and murine fibroblasts has been shown to cause slight alkalisation of the lysosomes (Jiang et aI., 
1990). Alkalisation of acidic compartments, such as endosomes and lysosomes, in tum, causes 
disturbances in protease processing and secretion (Nishimura et al., 1988). The use of the 
MCF-IOA and Neo-T cell lines provides a unique opportunity to study the possible effect of the 




MCF growth medium. See Section 4.4.1.1. 
1 mM LysoTracker Red stock solution. See Section 4.4.1.1. When required, it was diluted to a 
working strength of75 nM in MCF growth medium. 
7.4 mM C-2938 oxidative probe stock solution. See Section 4.4.1.1. When required, it was 
diluted to a working strength of 5 J.1M in MCF growth medium. 
4.4.5 Procedure 
MCF-I0A and Neo-T cells were grown to near confluence in MCF growth medium, in a 95% 
humidified atmosphere, containing 5% CO2, at 37°C. Cells were washed with HBSS, trypsinised 
with IX trypsin-EDTA solution, and seeded (at approx. 1 x 104 cells/well) into duplicate 12-well 
Nunc Multiwell plates, one plate containing a 22 nun diameter sterile glass coverslip in each well. 
When cells were near 60% confluence the coverslips were inverted and placed in the micro-
chamber described in Section 4.4.2. The cells were double labelled, first with the C-2938 
oxidative probe for 60 min at 37°C, followed by incubation in LysoTracker for 40 min at 37°C. 
The micro-chamber was flushed with MCF growth medium and the cells viewed with an 
epitluorescent microscope using the appropriate filters. The results were captured on XP2 400 
black and white film and analysed using National Institute of Health (NIH) image analysis 
software (NIH-image), which is available without cost on the internet. 
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4.5 Results 
4.5.1 The effect of cysteine concentration on three lysosomal enzymes 
The effect of cysteine concentration on the activity of cathepsins S and B and acid a-glucosidase 
is shown in Fig. 16. The activity of cathepsin L is also shown (Dennison et al., 1992). The 
activities of cathepsins S and B showed a similar increase in activity with increase in cysteine 
concentration. However, cathepsin S showed a 20% residual activity before activation with 
cysteine whereas cathepsin B showed zero activity, the same as cathepsin L. Acid a-glucosidase 
showed only a slight fluctuation of activity over the range of cysteine concentrations. The three 
cysteine cathepsins all showed the greatest increase in activation up to 30 mM cysteine and 
thereafter their activity increased less and in the case of cathepsin S and B the activity decreased 
slightly after a cysteine concentration in excess of 100 mM. 
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Figure 16. The effect of cysteine concentration on the activity of cathepsins S, B and L and acid a.-glucosidase. 
Artificial substrate hydrolysis by equimolar amounts of the enzymes was measured in standard 10 min 
assays using constant pH buffers containing a range of cysteine concentrations, as described in Section 
4.3 . Cathepsin S (e), cathepsin B (0), acid a.-glucosidase (0), cathepsin L <-) (Denitison 
et al., 1992). Each point represents the mean of three determinations. 
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4.5.2 Emission profiles of LysoTracker and C-2938 
The emission profiles ofLysoTracker and C-2938 are illustrated in Fig. 17. LysoTracker, excited 
at 560 nm, emitted at 595 nm, while C-2938, excited at 490 nm, emitted at 525 nm. A mixture 
of the two dyes excited at their respective wavelengths gave identical emission profiles. 
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Figure 17. Emission spectra ofC-2938 and LysoTracker. 
C-2938 was excited at 490 DID and LysoTracker was excited at 560 DID, (-) A and (-) B represent the 
respective emission profiles, while (-) I and (-) II represent the emission generated by reflection of the 
excitation beam. ( ... ), represents the emission profiles when a mixture of the two dyes was excited at 
their respective wavelengths. 
4.5.3 Qualitative measurement of the redox potential of acidic compartments in vivo 
MCF-lOA and MCF-I0A-Neo-T breast epithelial cell lines were labelled with C-2938 and 
LysoTraker, as described in Section 4.4.5, and the resulting fluorescent patterns (Fig. 18 and 19) 
were photographed and analysed on Nlli-image analysis software to ascertain where the two 
fluorescent images overlapped. The overlap between fluorescent patterns indicates which of the 
acidic organelles correspond with organelles which are oxidising. The fluorescent intensity of 
C-2938 gives an indication of the redox potential in a particular acidic organelle. 
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Figure 18. MCF-IOA breast epithelial cell labelled with C-2938 and LysoTracker. 
Cells were incubated, in culture medium, with C-2938 for 1 h at 37°C, followed by LysoTracker for 40 min 
at 37°C (Section 4.2.1). The results were viewed and photographed through an epifluorescent microscope 
with excitation at 560 run for LysoTracker (A) and 490 run for C-2938 (B). The photographs were analysed 
using the programme NllI-image (C). Yellow = LysoTracker, Purple = C-2938, Black = overlap between 
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Figure 19. MCF-I0A-Neo-T breast epithelial cell labelled with C-2938 and LysoTracker. 
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Cells were labelled as descnbed in Fig. 18. LysoTracker (A), C-2938 (B) and the composite Nlli-
image (C). Yellow = LysoTracker, Purple = C-2938, Black = overlap between the two dyes. The result 
shown is representative of (approximately) 5 replicate experiments. 
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4.6 Discussion 
The role of redox potential in the regulation of lysosomal function has been approached from two 
different angles. The first approach involved assessing the effect of increasing concentrations of 
the reducing agent cysteine on the three lysosomal enzymes isolated as described in Chapter 3. 
The effect of reducing agents on lysosomal enzyme activity was directly linked to the following 
in vivo experiment as it showed a possible way in which the redox potential could affect or even 
regulate certain lysosomal enzymes. This second, more direct, approach assessed the in vivo 
intralysosomal redox potential and whether this potential varied among the lysosomes of a single 
cell. This particular problem has not been previously addressed, so the experimental procedure 
had to be devised, optimised, and the validity of the results assessed. 
The activation profiles of the two lysosomal cysteine proteinases, cathepsins S and B (Fig. 16), with 
the reducing agent cysteine, were very similar. Both enzymes showed a sharp increase in activity up 
to 30 mM cysteine followed by a more gradual increase to maximal activity at 100 mM cysteine. This 
sharp activation gradient between 0 to 30 mM cysteine means that a small change in the cysteine 
concentration would significantly alter the enzymes' activity. Therefore, varying the reducing potential 
of the medium could constitute a regulatory mechanism for these enzymes. The response of a third 
lysosomal cysteine proteinase, cathepsin L (Dennison et ai., 1992), was included for comparison. Its 
activation was more uniform over the given range of cysteine concentrations and did not show the 
same rapid activation at lower cysteine concentrations. However, it still supports the idea that the 
reducing potential of the medium could affect its activity. An interesting difference between the 
activity of cathepsin S and that of cathepsins B and L is that cathepsin S shows residual activity in the 
absence of a reducing agent, whereas cathepsins B and L show no activity until they are activated by a 
reducing agent. The reason for this is unclear but it does mean that cathepsin S could remain partially 
active at all times. Cathepsin S, however, apparently has a limited tissue distribution, unlike cathepsins 
B and L which are ubiquitous. 
These results do not give any direct insight into the in vivo response of these enzymes to varying redox 
potentials. The need for a reducing agent for activation of these enzymes may be a result of oxidation 
of the active site cysteine during isolation. However, the results discussed here indicate a possible 
mechanism for regulating lysosomal cysteine cathepsin function by varying redox potential. 
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The activity of acid a-glucosidase did not significantly alter in the presence of the reducing agent, 
cysteine (Fig. 16). Its activity increased about 5% at 100 mM cysteine and decreased again, it 
was therefore concluded that a reducing environment had no direct effect on the activity of this 
enzyme. This was not unexpected as it does not have a cysteine residue in its active site, 
therefore it should not require activation by a reducing agent. However, as discussed in Chapter 
1, acid a-glucosidase digests the smaller ~-glycogen particles faster than the larger protein-rich, 
disulfide linked, a-glycogen particles. This is thought to be due to steric hindrance, as the 
a-particles hinder hydrolysis by not allowing the enzyme, once bound, to attack the glucosidic 
bonds (Calder and Geddes, 1989a). Reduction of the disulfide bridges of the a-particles by a 
reducing agent such as cysteine, and digestion of the protein core by the activated cysteine 
cathepsins, would liberate the smaller ~-particles which are more susceptible to enzymatic attack 
by acid a-glucosidase. Therefore, a reducing environment may indirectly form part of a 
regulatory mechanism of acid a-:-glucosidase on lysosomal glycogen, by making its substrate more 
susceptible to enzymatic attack, rather than by directly activating the enzyme. 
The effect of cysteine on the isolated lysosomal cysteine cathepsins was encouraging in the 
context of this study as it supports the hypothesis that intralysosomal redox potential may 
constitute part of a regulatory mechanism for lysosomal function. Therefore, the next step was 
to devise a method to assess the intralysosomal redox potential in living cells. This involved the 
development of some novel experimental approaches. The redox potential of a given system is 
governed by the relative amounts of reductant and oxidant, thus maintaining this system in its 
natural state during the assessment is crucial. Conventional labelling techniques involve 
permeablising, labelling and fixing the cells before viewing. This procedure was unsuitable for 
this experiment as permeablising and fixing the cells would destroy the natural intralysosomal 
redox potential, as this cannot be maintained without the reducing and oxidising molecules. To 
measure the potential within lysosomes, the intralysosomal redox potential must be maintained at, 
or as near to, its natural state as possible. Therefore, the labelling procedure was carried out on 
cultured cells, in the stable environment of a cell culture incubator. 
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The crucial problem centred around the development of a specific redox indicator system which would 
target the lysosome. Since no previous experimental procedure had been devised to assess the 
intralysosomal redox potential, a novel system was developed as described in Section 4.4. Using this 
system it was possible to qualitatively assess the redox status of the intralysosomal milieu. The 
oxidative probe (C-2938), which is not selectively loaded into lysosomes, was used in conjunction 
with a lysosomal marker dye, LysoTracker. The two probes fluoresce with different excitation 
wavelengths, making it possible to load both into the same cell and view the two different fluorescent 
patterns separately. This was achieved by using an epifluorescent microscope with specific excitation 
filters for the two dyes, making it possible to excite each dye separately. 
The emission profiles of the two dyes were assessed (Fig. 17) before they were used in the experiment. 
These emission profiles were generated by exciting the dyes at their specific excitation wavelengths 
and scanning the emission spectra. Both emission spectra showed two peaks, one at the same point as 
the excitation wavelength and another smaller emission peale The first peak was due to reflected 
excitation light which is recorded by the emission sensor. The second peak represented the emission 
wavelength of each dye, with LysoTracker and C-2938 showing emission peaks at 595 nm and 
525 nm respectively. These values compare favourably with the reported emission values for these 
dyes, with LysoTracker reported to emit at 592 nm and C-2938 at 518 nm (Molecular Probes bulletin 
No. 21). A second experiment was carried out to see the effect that mixing the dyes would have on 
their emission profiles. This was relevant as it was imperative that a specific excitation wavelength 
only caused fluorescence of one dye, otherwise it would be impossible to distinguish whether the 
emission pattern was due to specific cellular conditions or just an interaction between the two dyes. 
The emission profiles showed no change when the dyes were mixed which indicated that they had no 
effect on each other, so it may be concluded that fluorescent patterns should not be influenced by a 
cross-reaction between the dyes. 
Viewing the labelled cells posed some problems of its own. If the cells were stressed in any way 
during viewing it would alter the results, as the labelling system developed in this study is 
dynamic and would indicate any change in redox status caused by stress. Conventional viewing 
involved mounting the cells on a microscope slide in order to view them under an epifluorescent 
microscope. In this system the cells would no longer be immersed in culture medium, and would 
soon become stressed through lack of nutrients and oxygen. Moreover, it was found that cells on 
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a slide coved by a coverslip were distorted by the weight of the coverslip. This led to the 
development of a special purpose micro-chamber which allowed for viewing of live cells while 
still immersed in culture medium. This effectively reduced the possibility of artefacts being 
produced by abnormal cellular responses to external factors which could not be easily controlled. 
However, the mounting slide was not temperature controlled so all the procedures prior to 
viewing were done in the temperature controlled environment of the cell culture incubator. 
Viewing times, therefore, were limited so that the temperature of the cultured cells environment 
would not vary too much. An obvious modification to this micro-chamber would be the addition 
of a mechanism to control the temperature. For the immediate purpose, however, this was not 
considered necessary. 
In order to evaluate the fluorescent patterns generated by the two dyes, the images had to be 
accurately compared. To achieve this, photographs were taken of the fluorescent patterns, and the 
amount of overlap between the two images was assessed. Initially colour photographs of the 
fluorescent patterns were attempted, in order to show the different fluorescent colours of the .dyes, but 
colour film was not sensitive enough to capture the images, as so little light was emitted. For this 
reason, also, it was not possible to capture the images directly by video camera. The problem was 
compounded by the fact that the dyes were rapidly quenched, i.e. their fluorescence decreased rapidly 
with time of exposure to the excitation wavelength. This complicated determination of optimal 
photographic exposure times. To solve this problem in future studies, a computer controlled 
automatic exposure system with spot metering was acquired but this equipment arrived too late to be 
useful in the present study. With advice from the Centre for Electron Microscopy, University of 
Natal" a sensitive black and white film (XP2-400) was used to capture the fluorescent images. 
However, this makes the images look similar, as the colour difference was no longer apparent. 
Following the successful capturing of the images, a suitable method for comparing the images was 
required. The most accurate method proved to be an image analysis software package developed by 
the Nlli. The photographic images were transferred, via a video camera link-up, into the image 
analysis program, where a graphic representation of the fluorescent patterns was made. The two 
different patterns were then overlaid and rendered in artificial colour to highlight where the images 
overlapped. 
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Using the black and white photographs and the composite image it was possible, firstly, to see which 
of the acidic organelles showed fluorescence of the oxidative probe, and secondly, · to see the 
fluorescent intensity of the oxidative probe in the acidic organelles, which would indicate the level of 
oxidation. Using these criteria the fluorescent and composite images obtained from the MCF-I0A and 
MCF-I0A-Neo-T cell lines were analyzed to see if the oxidation status of the lysosomes varied within 
a single cell and also if the general intralysosomal oxidation/reduction levels in the two different cell 
lines differed. 
A significant result is that there was ~ fluorescence due to C-2938, as this throws into question the 
view that lysosomes are invariably reducing. The fluorescent patterns obtained from the 10A and 
Neo-T cells were not obviously different (Figs. 18 and 19 are representative of several replicate 
experiments conducted). From a simple visual inspection it could not be concluded that there was any 
difference in the number or distribution of acidic organelles, or that the number and intensity of 
oxidative organelles differed between the two cell lines. The difference was such that a conclusion 
could only be drawn if a large number of both cell types were analyzed which was not done in this 
preliminary study. The only obvious difference between the two was the shape of the cells, with the 
Neo-T cells being more elongated, while the 10A cells maintained a more symmetrical shape. An 
interesting feature which can be seen in both cells is the presence of a single large acidic vesicle which 
also shows labelling with the oxidative probe. Similar large acidic vesicles have been studied by 
Montcourrier et al. (1990; 1994) but they reported that these large acidic vesicles were 2 to 20 fold 
more abundant in breast cancer cells than in normal mammary epithelial cells. However, in this study 
no difference in the number of large acid vesicles was seen between the transformed and non-
transformed cell lines. The large acidic vesicles might be involved in digestion of insoluble 
extracellular matrix constituents. The present cells were grown on liquid media and this might have 
suppressed development of the large acid vesicles. As no conclusive difference could be seen between 
the two cell lines the results discussed will concentrate on the 10A cell (Fig. 18) as this represents the 
closest to the normal condition. 
The fact that the internal milieu of some of the acidic organelles (lysosomes) were able to oxidise the 
C-2938 probe, while others showed no fluorescence, suggests that there is a difference in the redox 
potential of the acid organelles. Also, the few organelles which lit up with C-2938, but not with 
LysoTracker, might correspond with the non-acidic lysosomes reported by Butor et al. (1995) 
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(Chapter 5). The photograph of the oxidative dye shows a range of fluorescent intensity which can be 
interpreted as a variable redox potential between the lysosomes of a single cell. This preliminary result 
supports the hypothesis that the redox potential might be a controlling influence upon lysosomal 
function. 
The system devised in this study is novel but has not been perfected. The results suggest that a 
more extensive, and quantitative, analysis is required. Challenges that remain are, i) how to 
quantitatively measure the intralysosomal redox potential in living cells and ii) how to measure 





Lysosomes are traditionally defined as acidic terminal compartments of the endocytic pathway 
that are devoid of recycling receptor molecules and enriched in the lamp/lgp class of membrane 
glycoproteins (of unknown function), as well as in acid hydrolases (Griffiths et ai., 1988; 
Kornfeld and Mellman, 1989). However, these "markers" are also found in high concentrations 
in structures now referred to as late endosomes (which are kinetically earlier than lysosomes). 
Therefore, the interpretation of a "lysosome" is being redefined as more knowledge is 
accumulated on the endosomal-Iysosomal pathway. In this dissertation the methods used were 
unable to distinguish between lysosomes and late endosomes and the term "lysosome" therefore 
refers to lysosomes and late endosomes 'unless otherwise stated. 
The rapid development of m~re sensitive and specific techniques for studying endosomal-
lysosomal biogenesis have made it possible to acquire information in ways which were previously 
not possible. Current observations on the function of the endosomal-Iysosomal pathway suggest 
a far more dynamic system which may be able to respond to changes in the needs of a cell, thus 
making this far more than "just a system for continuous degradation of proteins and other 
molecules". The membranes of the endosomes and lysosomes may also be more than just 
cordons protecting the cytoplasm from the dangerous brew of hydrolytic enzymes. Their 
"permeability" properties increasingly appear to be tailor-made to regulate their function, as more 
specific membrane transporters are being discovered. 
In this study the role of the redox potential on lysosomal function has been investigated using 
some novel techniques. For their role in proteolysis, lysosomes must be reducing, both for the 
function of the cysteine cathepsins and for the reduction of disulfide bonds in the substrate 
proteins. This raised the question of whether the intralysosomal milieu is invariably reducing and 
proteolytic or whether the intralysosomal redox status and thus proteolytic activity may be 
variable, which in effect would be a switch between "on" or "off' limits at different times. 
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The results obtained in this study gave further insight into this hypothesis. They show that the 
activity of the lysosomal cysteine cathepsins, in vitro, is sensitive to the concentration of reducing 
agent present in the assay. Therefore, the redox potential in the in vivo medium could similarly 
affect their activity, thus constituting part of a regulatory mechanism for proteolysis in the 
lysosome. This hypothesis is supported by the results of the in vivo experiments on the redox 
potential in lysosomes. These results were interesting: firstly the mere fact that there was any 
C-2938 labelling means that the conventional view, i.e. that lysosomes are invariably reducing, 
must be questioned. Secondly, the lysosomes showed variable oxidation of the dye which 
suggests that the intralysosomal redox status may not be uniform in the lysosomes of a single cell. 
Thirdly, a few organelles labelled with C-2938 but not with LysoTracker,which could be 
interpreted as non-acidic lysosomes, showing a certain amount of oxidation of C-2938. This 
interpretation is supported, to some extent, by the recent results of Butor et aI. (1995) which 
suggest that lysosomes may not always be strongly acidic. 
Some lysosomal hydrolases have shown substantial residual activity in a more alkaline pH range 
(Kirschke and Barrett, 1980; Dawson and Tsay, 1977). Furthermore, prior studies have 
suggested that sialic acid-specific O-acetylesterase (Riga et aI., 1989; Butor et al., 1993a,b) and 
a glycosylasparaginase (Tollersrud and Aronson, 1992; Mononen et al., 1993), which have 
neutral pH optima, were found in lysosomes (Butor et aI., 1995). Dehrmann et al. (1995;1996) 
have also shown that the lysosomal cysteine proteinase cathepsin B also has an alkaline pH 
optimum. These apparently paradoxical observations were explored by Butor et al. (1995) . 
Factors modifying the pH/activity profiles of these enzymes could not be found in lysosomal 
extracts, therefore, Butor et af. (1995) postulated that the function of the enzymes with neutral 
pH optima must either depend upon their minimal residual activity at acid pH, or the possibility 
that lysosomes are not always strongly acidic. Since most methods used to identify lysosomes 
take advantage of their acid interior (Ohkuma and Poole, 1978; Yamashiro and Maxfield, 
1987a,b; Anderson and Orci, 1988), a subset of lysosomes with neutral pH at the time of 
observation may have been previously missed. Therefore, to detect lysosomes in living cells 
without regard to internal pH, Butor et af. (1995) used the" uptake of a fluorescently labelled 
mannose-6-phosphate protein as a lysosomal marker. They showed that the labelled organelles 
did not all rapidly accumulate Acridine Orange, a vital stain that is specific for acidic 
compartments. From this they suggested that lysosomal pH may fluctuate, allowing hydrolytic 
92 
enzymes with a wide range of pH optima to efficiently degrade macromolecules. Butor et ai. 
(1995) concluded that the pH of the late endosomal and lysosomal compartments might be more 
dynamic than previously thought, fluctuating over a wide pH range, with a preference for a more 
acidic state. 
The results reported by Butor et ai. (1995) lend support to the idea that there are non-acidic 
lysosomes which show oxidation. However the C-2938 labelled organelles which do not 
correspond with LysoTracker labelling could be unrelated organelles as it is not conclusively 
known whether C-2938 is selectively loaded into lysosomes. Thus establishing how selectively 
C-2938 is loaded into lysosomes is necessary in further studies. 
Another perspective linked to pH regulation is the effect pH has on the lysosomal redox status. 
The redox potential generated by a specific redox pair, in this case cystine and cysteine, varies 
not only according to the concentration of each species but also with the pH of the medium. The 
lower the pH, the easier it will be to reduce the oxidised molecules ( cystine) of the redox pair, 
and the harder it will be to oxidise the reduced molecules (cysteine) (Kyte, 1995). This means 
that when the lysosome is more acidic it will have a lower reducing potential or higher oxidising 
potential for the same concentrations of a redox pair. Therefore, any future studies on either 
lysosomal pH or redox potential will have to take note of this relationship and establish what 
effect it has on the' system under investigation. This link between redox potential and pH may 
give further insight into a very dynamic lysosomal regulation system. 
The in vivo experiments carried out in this project were novel and considerable time was spent 
developing the techniques. The results constitute preliminary findings and a great deal can still be 
done to further perfect this technique, both in execution and interpretation of the results. In this 
study the results were qualitative as time constraints did not allow for the fluorescent intensity of 
the dye to be calibrated with respect to redox potential and pH. . Therefore, the intensity of 
fluorescence could not be quantitatively correlated with a level of oxidation but rather the 
variance of fluorescence intensity could only be interpreted qualitatively. Quantitative 
measurement of intraorganelle fluorescence has recently been described. Overly et al. (1995) 
quantitatively measured the pH in the endosomal-Iysosomal pathway in neurons using radiometric 
imaging with pyranine. This technique may prove to be difficult to transfer to the present study, 
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however, as the neurons studied by Overly et al. (1995) only contained a few relatively large acid 
organelles which could easily be distinguished from each other. In the present study the labelled 
organelles were not only small but also relatively clumped together, making it more difficult to 
differentiate the individually labelled organelles. 
Further work could also be done to assess if the redox status of the lysosomes changes with time. 
A single cell could be continuously viewed and photographed at specific time intervals. This 
would give a dynamic picture of the intralysosomal redox status and the movement of the 
lysosomes within the cell. This could be done by modifying the micro-chamber so that the 
chamber could be temperature controlled, either in itself, say with Peltier couples, or by using a 
heated microscope stage. Using this system, further experiments could also be done to see the 
effect of cell stress such as anoxia on the intralysosomal redox potential. This type of experiment 
could give greater insight into the possible role of redox potential in lysosomal regulation. 
A number of models have been proposed for the mechanism of the endosomal-Iysosomal pathway 
and the principal ones have been briefly discussed in Chapter 1. However, further comment is 
required on a model very recently proposed by Griffiths (1996) as it provides some interesting 
insights to the present study. In this model Griffiths (1996) suggest that the membrane organelles 
involved in the endosomal-Iysosomal pathway may be classified either as "vesicles" or 
"compartments" (see page 2 for definition). He argues that the lysosomes are "vesicles", namely 
of membrane cargo which bud off the late endosomal "compartment" and periodically fuse back 
with the same "compartment" in a regulated manner (Fig. 20). Thus the function of the 
lysosome, as defined by Griffiths (1996), is to store mature lysosomal enzymes in a form such 
that they can be readily injected, by fusion, into late endosomal compartments, when needed. In 
this modellysosomes are more akin to storage vesicles, while the late endosomes are collectively, 
visualised in Griffiths' (1996) words, as the cell "stomach". However, little is known about the 
relative in vivo degradative abilities of the two sets of organelles. If, as Griffiths (1996) suggests, 
the late endosome represents the major compartment where degradation occurs and the 
lysosomes are mostly storage vesicles, a prediction is that lysosomes should fuse in vitro with 
purified late endosomes but not with themselves. Yet despite the vast literature on lysosomes 
over the past thirty years the structural and functional relationship between the late endosomes 
and lysosomes requires more attention. 
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Figure 20. The endosomal-Iysosomal pathway. 
Materials are moved between the early and late endosomes by specialized shuttle vesicles which can 
not fuse with each other, but only with the early and late endosomal compartments. The lysosomes are 
also visualised as vesicles which bud off the late endosome and are able to again fuse with the late 
endosome but not with each other (adapted from Griffiths, 1996). 
Griffiths' (1996) theory that lysosomes may play more of a storage role, while the late endosome 
is the site for active protein degradation, is interesting in the context of this study. The methods 
used to analyse lysosomes in this study could not distinguish between lysosomes and late 
endosomes as the marker dye labelled all acidic organelles. With this in mind, the results 
obtained are not inconsistent with Griffiths' hypothesis. If lysosomes perform a storage function, 
the intralysosomal environment should not be conducive to proteolytic action and, therefore, may 
be more oxidising. Thus, the acidic organelles which showed labelling with the oxidative probe 
C-2938 could be lysosomes, in terms of Griffiths (1996) theory, while the acidic organelles which 
showed no labelling with C-2938 could be late endosomes, having a reducing interior and 
consequently active thiol proteinases for protein digestion. The concept of lysosomes as redox-
dependent storage vesicles is also consistent with the observations on lysosomal glycogen, which 
is stored in a protein-crosslinked form. In fact, this hypothesis provides a tentative answer to the 
question, "why are lysosomal proteinases cysteine proteinases?" The answer being that only 
these could be subject to redox regulation. 
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Our perception of lysosomes is subject to constant review, in the light of new evidence. The 
latest view, put forward in the review by Griffiths (1996), is of a complex and dynamic 
lysosomellate endosome system, in which lysosomes perform a storage role. The contribution of 
the studies reported in this dissertation has been to draw together evidence, both from the 
literature and from original experiments, on how lysosomes might perform this storage role, i.e. 
through redox-regulation of enzyme activity. The studies reported here represent a tentative 
beginning but may have opened a door to a new research field . 
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